AB 512: Health care coverage: prior authorization.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2025-09-12
Current Status:
Failed
(2026-01-22: Consideration of Governor's veto stricken from file.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services, including pursuant to contracts with various types of managed care plans. Existing law generally authorizes a health care service plan, including a Medi-Cal managed care plan, or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would change the timeline for prior or concurrent authorization requests to no more than 3 business days from the plans or insurers receipt via electronic submission, or 5 business days from receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan or insurer to make the determination. The bill would require a utilization review decision to be made within 24 hours from receipt of a prior or concurrent authorization request via electronic submission, or 48 hours from receipt via submission that is not electronic, if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program. The bill would exclude Medi-Cal managed care plans from the above-described timeline changes.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services, including pursuant to contracts with various types of managed care plans. Existing law generally authorizes a health care service plan, including a Medi-Cal managed care plan, or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would change the timeline for prior or concurrent authorization requests to no more than 3 business days from the plans or insurers receipt via electronic submission, or 5 business days from receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan or insurer to make the determination. The bill would require a utilization review decision to be made within 24 hours from receipt of a prior or concurrent authorization request via electronic submission, or 48 hours from receipt via submission that is not electronic, if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program. The bill would exclude Medi-Cal managed care plans from the above-described timeline changes.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services, including pursuant to contracts with various types of managed care plans. Existing law generally authorizes a health care service plan plan, including a Medi-Cal managed care plan, or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would change the timeline for prior or concurrent authorization requests to no more than 3 business days from the plans or insurers receipt via electronic submission, or 5 business days from receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan or insurer to make the determination. The bill would require a utilization review decision to be made within 24 hours from receipt of a prior or concurrent authorization request via electronic submission, or 48 hours from receipt via submission that is not electronic, if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program. The bill would exclude Medi-Cal managed care plans from the above-described timeline changes.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law generally authorizes a health care service plan or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would shorten change the timeline for prior or concurrent authorization requests to no more than 48 hours for standard requests or 24 hours for urgent requests from the plans or insurers receipt 3 business days from the plans or insurers receipt via electronic submission, or 5 business days from receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan or insurer to make the determination. The bill would require a utilization review decision to be made within 24 hours from receipt of a prior or concurrent authorization request via electronic submission, or 48 hours from receipt via submission that is not electronic, if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law generally authorizes a health care service plan or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would shorten the timeline for prior or concurrent authorization requests to no more than 48 hours for standard requests or 24 hours for urgent requests from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law generally authorizes a health care service plan or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would shorten the timeline for prior authorization requests to no more than 48 hours for standard requests or 24 hours for urgent requests from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers by the Department of Insurance. Existing law generally authorizes a health care service plan or disability insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. For a request prior to or concurrent with the provision of health care services, existing law requires utilization review decisions to be made within 5 business days from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination, or within 72 hours if the enrollee or insured faces an imminent and serious threat to their health or the normal timeframe would be detrimental to their life or health, as specified.
This bill would shorten the timeline for prior authorization requests to no more than 48 hours for standard requests or 24 hours for urgent requests from the plans or insurers receipt of the information reasonably necessary and requested by the plan or insurer to make the determination. Because a willful violation of this provision by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (2) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed three business days from the plans receipt via electronic submission, or five business days from the plans receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 24 hours from the plans receipt via electronic submission, or 48 hours from the plans receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(3)Notwithstanding paragraphs (1) and (2), for a Medi-Cal managed care plan contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.9 (commencing with Section 14700) of Part 3 of Division 9 of the Welfare and Institutions Code, both of the following apply:
(A)Decisions to approve, modify, or deny, based on medical necessity, requests by providers prior to, or concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by subparagraph (B), shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(B)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in subparagraph (A), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1), (2), or (3) because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraph (1), (2), or (3) or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1), (2), or (3), whichever applies.
(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (2), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed three business days from the insurers receipt via electronic submission, or five business days from the insurers receipt via submission that is not electronic, of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the insurer, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 24 hours from the insurers receipt via electronic submission, or 48 hours from the insurers receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules.
(3)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(5)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraph (1) or (2) or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), whichever applies.
(6)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (2) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed three business days from the plans receipt via electronic submission, or five business days from the plans receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 24 hours from the plans receipt via electronic submission, or 48 hours from the plans receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(3)Notwithstanding paragraphs (1) and (2), for a Medi-Cal managed care plan contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), Chapter 8.75 (commencing with Section 14591), or Chapter 8.9 (commencing with Section 14700) of Part 3 of Division 9 of the Welfare and Institutions Code, both of the following apply:
(A)Decisions to approve, modify, or deny, based on medical necessity, requests by providers prior to, or concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by subparagraph (B), shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(B)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in subparagraph (A), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1), (2), or (3) because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraph (1), (2), or (3) or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1), (2), or (3), whichever applies.
(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (2), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed three business days from the insurers receipt via electronic submission, or five business days from the insurers receipt via submission that is not electronic, of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the insurer, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 24 hours from the insurers receipt via electronic submission, or 48 hours from the insurers receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules.
(3)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(5)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraph (1) or (2) or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), whichever applies.
(6)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (2) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed three business days from the plans receipt via electronic submission, or five business days from the plans receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 24 hours from the plans receipt via electronic submission, or 48 hours from the plans receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(3)Notwithstanding paragraphs (1) and (2), for a Medi-Cal managed care plan contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), Chapter 8.75 (commencing with Section 14591), or Chapter 8.9 (commencing with Section 14700) of Part 3 of Division 9 of the Welfare and Institutions Code, both of the following apply:
(A)Decisions to approve, modify, or deny, based on medical necessity, requests by providers prior to, or concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by subparagraph (B), shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(B)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in subparagraph (A), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(3)(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(5)(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) (1), (2), or (3) because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraph (1) or (2) (1), (2), or (3) or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), (1), (2), or (3), whichever applies.
(6)(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (2), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed three business days from the insurers receipt via electronic submission, or five business days from the insurers receipt via submission that is not electronic, of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the insurer, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 24 hours from the insurers receipt via electronic submission, or 48 hours from the insurers receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules.
(3)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(5)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraph (1) or (2) or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), whichever applies.
(6)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, urgent means the enrollees condition is such that the enrollee faces an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function.(2)(1)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with prior to, or concurrent with, the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (3) (2) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 48 hours three business days from the plans receipt via electronic submission, or five business days from the plans receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)(2)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), (1), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with prior to, or concurrent with, the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 24 hours from the plans receipt via electronic submission, or 48 hours from the plans receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 and applicable federal interoperability rules. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(4)(3)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)(4)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(6)(5)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2) because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2) or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2), whichever applies.
(7)(6)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to insureds shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, urgent means the insureds condition is such that the insured faces an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function.(2)(1)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with prior to, or concurrent with, the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (3), (2), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed 48 hours three business days from the insurers receipt via electronic submission, or five business days from the insurers receipt via submission that is not electronic, of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the insurer, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)(2)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), (1), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with prior to, or concurrent with, the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 24 hours from the insurers receipt via electronic submission, or 48 hours from the insurers receipt via submission that is not electronic, or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, electronic submission means submission through an electronic portal designated by the plan, or an electronic submission in accordance with Section 130290 of the Health and Safety Code and applicable federal interoperability rules.
(4)(3)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)(4)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(6)(5)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2) because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2) or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, paragraph (1) or (2), whichever applies.
(7)(6)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, urgent means the enrollees condition is such that the enrollee faces an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function.
(2)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (3) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days 48 hours from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 24 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, whichever applies.
(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to insureds shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, urgent means the insureds condition is such that the insured faces an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function.
(2)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (3), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed five business days 48 hours from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 72 24 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(6)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, whichever applies.
(7)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, urgent means the enrollees condition is such that the enrollee faces an imminent and serious threat to their health, including including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function.
(2)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (3) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, whichever applies.
(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including including, but not limited to, Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to insureds shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, urgent means the insureds condition is such that the insured faces an imminent and serious threat to their health, including including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function.
(2)Decisions based on medical necessity to approve, modify, or deny requests by providers concurrent with the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (3), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed five business days from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(3)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (2), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers concurrent with the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination.
(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification or of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(6)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframes specified in paragraphs (1) to (3), inclusive, or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraphs (1) to (3), inclusive, whichever applies.
(7)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including including, but not limited to, Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)A health care service plan and any entity with which it contracts for services that include utilization review or utilization management functions, that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A health care service plan that is subject to this section shall have written policies and procedures establishing the process by which the plan prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for plan enrollees. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to Section 1363.5. These policies and procedures, and a description of the process by which the plan reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, shall be filed with the director for review and approval, and shall be disclosed by the plan to providers and enrollees upon request, and by the plan to the public upon request.
(c)A health care service plan subject to this section, except a plan that meets the requirements of Section 1351.2, shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or pursuant to the Osteopathic Act, or, if the plan is a specialized health care service plan, a clinical director with California licensure in a clinical area appropriate to the type of care provided by the specialized health care service plan. The medical director or clinical director shall ensure that the process by which the plan reviews and approves, modifies, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, complies with the requirements of this section.
(d)If health plan personnel, or individuals under contract to the plan to review requests by providers, approve the providers request, pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)No An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, may shall not deny or modify requests for authorization of health care services for an enrollee for reasons of medical necessity. The decision of the physician or other health care professional shall be communicated to the provider and the enrollee pursuant to subdivision (h).
(f)The criteria or guidelines used by the health care service plan to determine whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall be consistent with clinical principles and processes. These criteria and guidelines shall be developed pursuant to the requirements of Section 1363.5.
(g)If the health care service plan requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the plan shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees, based in whole or in part on medical necessity, a health care service plan subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to enrollees shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. For purposes of this paragraph, urgent means the enrollees condition is such that the enrollee faces an imminent and serious threat to their health, including the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function.
(1)(2)Decisions based on medical necessity to approve, modify, or deny, based on medical necessity, deny requests by providers prior to, or concurrent with the provision of health care services to enrollees that do not meet the requirements for the time period for review required by paragraph (2), (3) shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed five business days from the plans receipt of the information reasonably necessary and requested by the plan to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)(3)When the enrollees condition is such that the enrollee faces an imminent and serious threat to the enrollees health, including, but not limited to, including the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), (2), would be detrimental to the enrollees life or health or could jeopardize the enrollees ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, concurrent with the provision of health care services to enrollees, shall be made in a timely fashion appropriate for the nature of the enrollees condition, not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the plans receipt of the information reasonably necessary and requested by the plan to make the determination. Nothing in this section shall be construed to alter the requirements of subdivision (b) of Section 1371.4. Notwithstanding Section 1371.4, the requirements of this division shall be applicable to all health plans and other entities conducting utilization review or utilization management.
(3)(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to enrollees shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the enrollees treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the enrollee in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the enrollees treating provider has been notified of the plans decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to enrollees shall be communicated to the enrollee in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the plans decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification of a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the enrollee may file a grievance with the plan pursuant to Section 1368, and in the case of Medi-Cal enrollees, shall explain how to request an administrative hearing and aid paid pending under Sections 51014.1 and 51014.2 of Title 22 of the California Code of Regulations.
(5)(6)If the health care service plan cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) paragraphs (1) to (3), inclusive, because the plan is not in receipt of all of the information reasonably necessary and requested, or because the plan requires consultation by an expert reviewer, or because the plan has asked that an additional examination or test be performed upon the enrollee, provided the examination or test is reasonable and consistent with good medical practice, the plan shall, immediately upon the expiration of the timeframe timeframes specified in paragraph (1) or (2) paragraphs (1) to (3), inclusive, or as soon as the plan becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the enrollee, in writing, that the plan cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The plan shall also notify the provider and enrollee of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the plan, the plan shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), paragraphs (1) to (3), inclusive, whichever applies.
(6)(7)If the director determines that a health care service plan has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the director may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected, in accordance with subdivision (a) of Section 1397. The administrative penalties shall not be deemed an exclusive remedy for the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(i)A health care service plan subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)A health care service plan subject to this section that reviews requests by providers prior to, retrospectively, or concurrent with, the provision of health care services to enrollees shall establish, as part of the quality assurance program required by Section 1370, a process by which the plans compliance with this section is assessed and evaluated. The process shall include provisions for evaluation of complaints, assessment of trends, implementation of actions to correct identified problems, mechanisms to communicate actions and results to the appropriate health plan employees and contracting providers, and provisions for evaluation of any corrective action plan and measurements of performance.
(k)(1)A health care service plan, including a specialized health care service plan that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An enrollees medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the enrollees medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter, including, but not limited to, Section 1363.5 including Section 1363.5, and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against enrollees in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to Section 1381 and by the State Department of Health Care Services pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the enrollee.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or a licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the enrollees medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A health care service plan subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department and the State Department of Health Care Services may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department and the State Department of Health Care Services may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(7)This subdivision applies to a Medi-Cal managed care plan only to the extent that the State Department of Health Care Services obtains any necessary federal approvals, and federal financial participation is not otherwise jeopardized.
(l)The director shall review a health care service plans compliance with this section as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, and shall include a discussion of compliance with this section as part of its report issued pursuant to that section.
(m)This section shall not apply to decisions made for the care or treatment of the sick who depend upon prayer or spiritual means for healing in the practice of religion as set forth in subdivision (a) of Section 1270.
(n)Nothing in this This section shall not cause a health care service plan to be defined as a health care provider for purposes of any provision of law, including, but not limited to, including Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 2.Section 10123.135 of the Insurance Code is amended to read:10123.135.(a)Every disability insurer, or an entity with which it contracts for services that include utilization review or utilization management functions, that covers hospital, medical, or surgical expenses and that prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, or that delegates these functions to medical groups or independent practice associations or to other contracting providers, shall comply with this section.
(b)A disability insurer that is subject to this section, or any entity with which an insurer contracts for services that include utilization review or utilization management functions, shall have written policies and procedures establishing the process by which the insurer prospectively, retrospectively, or concurrently reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers of health care services for insureds. These policies and procedures shall ensure that decisions based on the medical necessity of proposed health care services are consistent with criteria or guidelines that are supported by clinical principles and processes. These criteria and guidelines shall be developed pursuant to subdivision (f). These policies and procedures, and a description of the process by which an insurer, or an entity with which an insurer contracts for services that include utilization review or utilization management functions, reviews and approves, modifies, delays, or denies requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, shall be filed with the commissioner, and shall be disclosed by the insurer to insureds and providers upon request, and by the insurer to the public upon request.
(c)If the number of insureds covered under health benefit plans in this state that are issued by an insurer subject to this section constitute at least 50 percent of the number of insureds covered under health benefit plans issued nationwide by that insurer, the insurer shall employ or designate a medical director who holds an unrestricted license to practice medicine in this state issued pursuant to Section 2050 of the Business and Professions Code or the Osteopathic Initiative Act, or the insurer may employ a clinical director licensed in California whose scope of practice under California law includes the right to independently perform all those services covered by the insurer. The medical director or clinical director shall ensure that the process by which the insurer reviews and approves, modifies, delays, or denies, based in whole or in part on medical necessity, requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, complies with the requirements of this section. Nothing in this subdivision shall be construed as restricting the existing authority of the Medical Board of California.
(d)If an insurer subject to this section, or individuals under contract to the insurer to review requests by providers, approve the providers request pursuant to subdivision (b), the decision shall be communicated to the provider pursuant to subdivision (h).
(e)An individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, may shall not deny or modify requests for authorization of health care services for an insured for reasons of medical necessity. The decision of the physician or other health care provider shall be communicated to the provider and the insured pursuant to subdivision (h).
(f)(1)An insurer shall disclose, or provide for the disclosure, to the commissioner and to network providers, the process the insurer, its contracting provider groups, or any entity with which it contracts for services that include utilization review or utilization management functions, uses to authorize, delay, modify, or deny health care services under the benefits provided by the insurance contract, including coverage for subacute care, transitional inpatient care, or care provided in skilled nursing facilities. An insurer shall also disclose those processes to policyholders or persons designated by a policyholder, or to any other person or organization, upon request.
(2)The criteria or guidelines used by an insurer, or an entity with which an insurer contracts for utilization review or utilization management functions, to determine whether to authorize, modify, delay, or deny health care services, shall comply with all of the following:
(A)Be developed with involvement from actively practicing health care providers.
(B)Be consistent with sound clinical principles and processes.
(C)Be evaluated, and updated if necessary, at least annually.
(D)If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the policyholder in that specified case.
(E)Be available to the public upon request. An insurer shall only be required to disclose the criteria or guidelines for the specific procedures or conditions requested. An insurer may charge reasonable fees to cover administrative expenses related to disclosing criteria or guidelines pursuant to this paragraph that are limited to copying and postage costs. The insurer may also make the criteria or guidelines available through electronic communication means.
(3)The disclosure required by subparagraph (E) of paragraph (2) shall be accompanied by the following notice: The materials provided to you are guidelines used by this insurer to authorize, modify, or deny health care benefits for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your insurance contract.
(g)If an insurer subject to this section requests medical information from providers in order to determine whether to approve, modify, or deny requests for authorization, the insurer shall request only the information reasonably necessary to make the determination.
(h)In determining whether to approve, modify, or deny requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds, based in whole or in part on medical necessity, every insurer subject to this section shall meet the following requirements:
(1)Decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to insureds shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. For purposes of this paragraph, urgent means the insureds condition is such that the insured faces an imminent and serious threat to their health, including the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decisionmaking process for standard requests would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function.
(1)(2)Decisions based on medical necessity to approve, modify, or deny, based on medical necessity, deny requests by providers prior to, or concurrent with, concurrent with the provision of health care services to insureds that do not meet the requirements for the time period for review required by paragraph (2), (3), shall be made in a timely fashion appropriate for the nature of the insureds condition, not to exceed five business days from the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination. In cases where the review is retrospective, the decision shall be communicated to the individual who received services, or to the individuals designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and shall be communicated to the provider in a manner that is consistent with current law. For purposes of this section, retrospective reviews shall be for care rendered on or after January 1, 2000.
(2)(3)When the insureds condition is such that the insured faces an imminent and serious threat to the insureds health, including, but not limited to, including the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decisionmaking process, as described in paragraph (1), (2), would be detrimental to the insureds life or health or could jeopardize the insureds ability to regain maximum function, decisions to approve, modify, or deny requests by providers prior to, or concurrent with, concurrent with the provision of health care services to insureds shall be made in a timely fashion, appropriate for the nature of the insureds condition, but not to exceed 72 hours or, if shorter, the period of time required under Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations issued thereunder, after the insurers receipt of the information reasonably necessary and requested by the insurer to make the determination.
(3)(4)Decisions to approve, modify, or deny requests by providers for authorization prior to, or concurrent with, the provision of health care services to insureds shall be communicated to the requesting provider within 24 hours of the decision. Except for concurrent review decisions pertaining to care that is underway, which shall be communicated to the insureds treating provider within 24 hours, decisions resulting in denial, delay, or modification of all or part of the requested health care service shall be communicated to the insured in writing within two business days of the decision. In the case of concurrent review, care shall not be discontinued until the insureds treating provider has been notified of the insurers decision and a care plan has been agreed upon by the treating provider that is appropriate for the medical needs of that patient.
(4)(5)Communications regarding decisions to approve requests by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall specify the specific health care service approved. Responses regarding decisions to deny, delay, or modify health care services requested by providers prior to, retrospectively, or concurrent with the provision of health care services to insureds shall be communicated to insureds in writing, and to providers initially by telephone or facsimile, except with regard to decisions rendered retrospectively, and then in writing, and shall include a clear and concise explanation of the reasons for the insurers decision, a description of the criteria or guidelines used, and the clinical reasons for the decisions regarding medical necessity. Any written communication to a physician or other health care provider of a denial, delay, or modification or a request shall include the name and telephone number of the health care professional responsible for the denial, delay, or modification. The telephone number provided shall be a direct number or an extension, to allow the physician or health care provider easily to contact the professional responsible for the denial, delay, or modification. Responses shall also include information as to how the provider or the insured may file an appeal with the insurer or seek department review under the unfair practices provisions of Article 6.5 (commencing with Section 790) of Chapter 1 of Part 2 of Division 1 and the regulations adopted thereunder.
(5)(6)If the insurer cannot make a decision to approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2) paragraphs (1) to (3), inclusive, because the insurer is not in receipt of all of the information reasonably necessary and requested, or because the insurer requires consultation by an expert reviewer, or because the insurer has asked that an additional examination or test be performed upon the insured, provided that the examination or test is reasonable and consistent with good medical practice, the insurer shall, immediately upon the expiration of the timeframe timeframes specified in paragraph (1) or (2), paragraphs (1) to (3), inclusive, or as soon as the insurer becomes aware that it will not meet the timeframe, whichever occurs first, notify the provider and the insured, in writing, that the insurer cannot make a decision to approve, modify, or deny the request for authorization within the required timeframe, and specify the information requested but not received, or the expert reviewer to be consulted, or the additional examinations or tests required. The insurer shall also notify the provider and enrollee insured of the anticipated date on which a decision may be rendered. Upon receipt of all information reasonably necessary and requested by the insurer, the insurer shall approve, modify, or deny the request for authorization within the timeframes specified in paragraph (1) or (2), paragraphs (1) to (3), inclusive, whichever applies.
(6)(7)If the commissioner determines that an insurer has failed to meet any of the timeframes in this section, or has failed to meet any other requirement of this section, the commissioner may assess, by order, administrative penalties for each failure. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice to, and an opportunity for a hearing with regard to, the person affected. The administrative penalties shall not be deemed an exclusive remedy for the commissioner. These penalties shall be paid to the Insurance Fund.
(i)Every insurer subject to this section shall maintain telephone access for providers to request authorization for health care services.
(j)(1)A disability insurer, including a specialized health insurer that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through an entity that uses an artificial intelligence, algorithm, or other software tool for the purpose of utilization review or utilization management functions, based in whole or in part on medical necessity, shall comply with this section and shall ensure all of the following:
(A)The artificial intelligence, algorithm, or other software tool bases its determination on the following information, as applicable:
(i)An insureds medical or other clinical history.
(ii)Individual clinical circumstances as presented by the requesting provider.
(iii)Other relevant clinical information contained in the insureds medical or other clinical record.
(B)The artificial intelligence, algorithm, or other software tool does not base its determination solely on a group dataset.
(C)The artificial intelligence, algorithm, or other software tools criteria and guidelines complies with this chapter and applicable state and federal law.
(D)The artificial intelligence, algorithm, or other software tool does not supplant health care provider decisionmaking.
(E)The use of the artificial intelligence, algorithm, or other software tool does not discriminate, directly or indirectly, against insureds in violation of state or federal law.
(F)The artificial intelligence, algorithm, or other software tool is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services.
(G)The artificial intelligence, algorithm, or other software tool is open to inspection for audit or compliance reviews by the department pursuant to applicable state and federal law.
(H)Disclosures pertaining to the use and oversight of the artificial intelligence, algorithm, or other software tool are contained in the written policies and procedures, as required by subdivision (b).
(I)The artificial intelligence, algorithm, or other software tools performance, use, and outcomes are periodically reviewed and revised to maximize accuracy and reliability.
(J)Patient data is not used beyond its intended and stated purpose, consistent with the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code) and the federal Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), as applicable.
(K)The artificial intelligence, algorithm, or other software tool does not directly or indirectly cause harm to the insured.
(2)Notwithstanding paragraph (1), the artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity. A determination of medical necessity shall be made only by a licensed physician or licensed health care professional competent to evaluate the specific clinical issues involved in the health care services requested by the provider, as provided in subdivision (e), by reviewing and considering the requesting providers recommendation, the insureds medical or other clinical history, as applicable, and individual clinical circumstances.
(3)For purposes of this subdivision, artificial intelligence means an engineered or machine-based system that varies in its level of autonomy and that can, for explicit or implicit objectives, infer from the input it receives how to generate outputs that can influence physical or virtual environments.
(4)This subdivision shall apply to utilization review or utilization management functions that prospectively, retrospectively, or concurrently review requests for covered health care services.
(5)A disability insurer subject to this subdivision shall comply with applicable federal rules and guidance issued by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. The department may issue guidance to implement this paragraph within one year of the adoption of federal rules or the issuance of guidance by the federal Department of Health and Human Services regarding the use of artificial intelligence, algorithm, or other software tools. Such guidance shall not be subject to the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code).
(6)For purposes of implementing this subdivision, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Section 19130 of the Government Code, and Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and shall be exempt from the review or approval of any division of the Department of General Services.
(k)Nothing in this This section shall not cause a disability insurer to be defined as a health care provider for purposes of any provision of law, including, but not limited to, including Section 6146 of the Business and Professions Code, Sections 3333.1 and 3333.2 of the Civil Code, and Sections 340.5, 364, 425.13, 667.7, and 1295 of the Code of Civil Procedure.
SEC. 3.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
|
Date
|
Status
|
|---|---|
| Jan 22, 2026 | Consideration of Governor's veto stricken from file. |
| Oct 6, 2025 | Consideration of Governor's veto pending. |
| Oct 6, 2025 | Vetoed by Governor. |
| Sep 22, 2025 | Enrolled and presented to the Governor at 3 p.m. |
| Sep 10, 2025 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 67. Noes 2. Page 3219.). |
| Sep 9, 2025 | In Assembly. Concurrence in Senate amendments pending. |
| Sep 9, 2025 | Read third time. Passed. Ordered to the Assembly. (Ayes 30. Noes 0. Page 2656.). |
| Sep 8, 2025 | Read second time. Ordered to third reading. |
| Sep 5, 2025 | Read second time and amended. Ordered returned to second reading. |
| Sep 4, 2025 | Read third time and amended. Ordered to second reading. |
| Aug 29, 2025 | Read second time. Ordered to third reading. |
| Aug 29, 2025 | From committee: Do pass. (Ayes 5. Noes 0.) (August 29). |
| Aug 18, 2025 | In committee: Referred to suspense file. |
| Jul 14, 2025 | Read second time and amended. Re-referred to Com. on APPR. |
| Jul 10, 2025 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 9). |
| Jun 11, 2025 | Referred to Com. on HEALTH. |
| Jun 3, 2025 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 2, 2025 | Read third time. Passed. Ordered to the Senate. (Ayes 68. Noes 1. Page 1834.) |
| May 27, 2025 | Read second time. Ordered to third reading. |
| May 23, 2025 | From committee: Do pass. (Ayes 12. Noes 0.) (May 23). |
| May 14, 2025 | In committee: Set, first hearing. Referred to suspense file. |
| Apr 29, 2025 | Re-referred to Com. on APPR. |
| Apr 28, 2025 | Read second time and amended. |
| Apr 24, 2025 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 13. Noes 0.) (April 22). |
| Apr 21, 2025 | Re-referred to Com. on HEALTH. |
| Apr 11, 2025 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Feb 24, 2025 | Referred to Com. on HEALTH. |
| Feb 11, 2025 | From printer. May be heard in committee March 13. |
| Feb 10, 2025 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 10, 2025 | AB 512 Harabedian Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Sep 9, 2025 | Assembly 3rd Reading AB512 Harabedian et al. By Becker | Senate Floor |
Passed |
|
| Aug 29, 2025 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 18, 2025 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jul 9, 2025 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Health |
Passed |
|
| Jun 2, 2025 | AB 512 Harabedian Assembly Third Reading | Assembly Floor |
Passed |
|
| May 23, 2025 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 22, 2025 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| AARP | ** Support | |
| Adventist Health | ** Support | |
| AHIP | ** Against | |
| ALLIANCE OF CATHOLIC HEALTH CARE, INC. | ** Support | |
| ALS Association | ** Support | |
| America'S Health Insurance Plans | ** Against | |
| America'S Physician Groups | ** Against | |
| American Academy Of Pediatrics, California | ** Support | |
| American Cancer Society Cancer Action Network Inc. | ** Support | |
| American Diabetes Association | ** Support | |
| Association for Clinical Oncology | ** Support | |
| Association Of California Life And Health Insurance Companies | ** Against | |
| Association Of Northern California Oncologists | ** Support | |
| California Academy of Child and Adolescent Psychiatry | ** Support | |
| California Access Coalition | ** Support | |
| California Association Of Health Plans | ** Against | |
| California Association Of Medical Product Suppliers | ** Support | |
| California Behavioral Health Association | ** Support | |
| California Chamber of Commerce Local Health Plans of California | ** Against | |
| California Chapter American College Of Cardiology | ** Support | |
| California Children's Hospital | ** Support | |
| California Chronic Care Coalition | ** Support | |
| California Collaborative for Long-Term Services and Supports | ** Support | |
| California Commission on Aging | ** Support | |
| California Hospital Association | ** Support | |
| California Kidney Care Alliance | ** Support | |
| California Long Term Care Ombudsman Association | ** Support | |
| California Medical Association | ** Support | |
| California Neurology Society | ** Support | |
| California Nurses Association | ** Support | |
| California Orthopedic Association | ** Support | |
| California Podiatric Medical Association | ** Support | |
| California Psychological Association | ** Support | |
| California Retired Teachers Association | ** Support | |
| California Rheumatology Alliance | ** Support | |
| California Society of Health System Pharmacists | ** Support | |
| California Society Of Plastic Surgeons | ** Support | |
| California State Association of Psychiatrists | ** Support | |
| cleanearth4kids.org | ** Support | |
| District Hospital Leadership Forum | ** Support | |
| Fresenius Medical Care North America | ** Support | |
| Health Access California | ** Support | |
| Hemophilia Council Of California | ** Support | |
| Local Health Plans Of California | ** Against | |
| Loma Linda University Adventist Health Sciences Center | ** Support | |
| Medical Oncology Association Of Southern California | ** Support | |
| Mental Health America of California | ** Support | |
| National Health Law Program | ** Support | |
| Physician Association of California | ** Support | |
| Planned Parenthood Affiliates Of California | ** Support | |
| Saint Agnes Medical Center | ** Support | |
| san francisco marin medical society | ** Support | |
| Stanford Health Care | ** Support | |
| U.S. Pain Foundation | ** Support | |
| United Hospital Association | ** Support | |
| Western Center on Law & Poverty, INC. | ** Support |
GOVERNOR'S VETO
GV Bill Id:AB 512
Author:(Harabedian)
As Enrolled Ver:September 12, 2025
2/3 vote
SUMMARY
Shortens the decision timeline for prior or concurrent authorization requests for health plans and health insurers to be no longer than three business day for standard requests (instead of five days in existing law) if the request is made by electronic submission, and 24 hours for urgent requests involving an imminent and serious threat to the enrollee's health if the request if made by electronic submission or 48 hours (instead of 72 hours in existing law). Requires Medi-Cal managed care plan (MCMC) plan contracts with the Department of Health Care Services (DHCS) to meet the prior and concurrent authorization timeframes, rather than the faster turnaround timeframes required by this bill.
Senate Amendments
- Apply the shortened timeframe of three business days for standard requests and 24 hours for urgent requests to authorization requests submitted electronically.
- Define "electronic submission" to mean submission through an electronic portal designated by the health plan or health insurer, or an electronic submission in accordance with the California Health and Human Services Data Exchange Framework and applicable federal interoperability rules.
- Require MCMC plan contracts with DHCS to meet the existing law prior and concurrent authorization timeframes.
Governor's Veto Message
This bill would shorten the required response times for health plans and insurers for prior authorization (PA) requests submitted by providers. For standard requests submitted electronically, the timeline would be shortened from five business days to three business days. For urgent requests, the required response timeline would be 24 hours for requests submitted electronically and 48 hours for requests that are not submitted electronically.
I strongly support the goal of improving the PA process. Accordingly, I recently signed SB 306 (Becker), which seeks to ensure that enrollees receive timely responses to requests for care by taking a holistic approach to improve the PA process. Under this new law, health plans and health insurers are required to submit data to the California Department of Managed Health Care and the California Department of Insurance, respectively, regarding the types of health care services subject to PA requirements. The departments must analyze the data and then issue a list of services that should not be subject to a PA requirement by 2027.
I am concerned that this bill's significantly shortened deadlines may inadvertently increase the number of denials and force health care plans to make critical decisions with incomplete or inaccurate information. I believe SB 306 is a more balanced approach to improve the PA system as a whole, alleviate burdens for providers, and improve patient outcomes in the long term.
COMMENTS
Prior authorization is a form of utilization review or utilization management. Utilization review can occur prospectively, retrospectively, or concurrently, and a plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, plans, and enrollees or insureds. There are timelines in the law for plans and insurers to respond to requests once any medical information that is reasonably necessary to make the determination is provided (as described in the summary above). Under this bill, the current law requirements would still apply to MCMC and Program of All-Inclusive Care for the Elderly (PACE) plans, and this bill does affect the existing prescription drug prior authorization requirements.
In 2023, at the request of the Legislature, the California Health Benefits Review Program (CHBRP) conducted a survey of California-regulated plans and insurers and found overall, between 5% and 15% of all covered medical services, and between 16% and 25% of pharmacy benefits, were subject to prior authorization requirements. CHBRP's survey of state regulated health plans and insurers shows the average time for a manual prior authorization by phone, mail, or fax in 2022 was 100-120 hours (medical benefit) and 30.5-55 hours for pharmacy benefit. For electronic prior authorizations in 2022 the average response time was 12-46 hours (medical benefit) and 31-69 hours for pharmacy benefit.
According to the Author
Delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. The author continues that this bill ensures that health insurers make prior authorization decisions within three business days instead of five days for standard requests submitted electronically, and 24 hours (if submitted electronically) instead of 48 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. The author concludes that by streamlining the process, the bill improves access to care, lowers avoidable health care expenses, and allows providers to focus on patient needs.
Arguments in Support
The California Medical Association (CMA), sponsor of this bill, states that burdensome PA processes contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. CMA continues that adding to these delays are the sluggish response times by health plans to prior authorization requests. CMA states that California currently has some of the slowest response timelines in the nation – 5 business days for non-urgent requests and 72 for urgent requests. CMA argues that these slow-moving response times lead to delays that negatively impact patient health. CMA continues that current prior authorization timelines are inadequate for many patients, and delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians. CMA concludes that by shortening response timelines, this bill ensures that health plans respond to a prior authorization request in a timelier manner, avoiding unnecessary delays to crucial medical care that have resulted in unnecessary pain, the worsening of patients' illnesses and in some cases even death.
Arguments in Opposition
America's Health Insurance Plans (AHIP) believes shortened PA timeframes are not the right approach. AHIP says almost half of PA requests are submitted manually. AHIP launched an initiative to understand the impact of electronic prior authorization that demonstrated faster time to patient care, faster time to decision, and improved information for providers. AHIP says insurance plans have recently announced a series of commitments to streamline and simplify prior authorization, including standardizing electronic prior authorization with a new framework operational and available to plans and providers by January 1, 2027. By 2027 for all coverage types of signatory plans at least 80% of prior authorizations will be answered in real-time. The California Association of Health Plans, the Association of California Life and Health Insurance Companies, and America's Physician Groups propose an alternative to this bill that would mandate all request be submitted electronically, require all necessary information to make an appropriate determination which means plans and insurers can answer at least 80% in real time, and the effective date should be delayed to allow providers sufficient time to comply with electronic submission requirements.
FISCAL COMMENTS
According to the Senate Appropriations Committee:
- The Department of Managed Health Care estimates costs of approximately $314,000 in 2025-26, $689,000 in 2026-27, $671,000 in 2027-28, $951,000 in 2028-29, and $944,000 in 2029-30 and annually thereafter for state operations (Managed Care Fund).
- California Department of Insurance estimates costs of $9,000 in 2025-26 and $21,000 in 2026-27 for state operations (Insurance Fund).
- Unknown potential cost pressures to capitation payments for Medi-Cal managed care plans for administration (General Fund and federal funds).
VOTES
ASM HEALTH: 13-0-3
YES: Bonta, Addis, Aguiar-Curry, Rogers, Carrillo, Mark González, Krell, Patel, Celeste Rodriguez, Sanchez, Schiavo, Sharp-Collins, Stefani
ABS, ABST OR NV: Chen, Flora, Patterson
ASM APPROPRIATIONS: 12-0-3
YES: Wicks, Arambula, Calderon, Caloza, Dixon, Elhawary, Fong, Mark González, Hart, Pacheco, Pellerin, Solache
ABS, ABST OR NV: Sanchez, Ta, Tangipa
ASSEMBLY FLOOR: 68-1-10
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Connolly, Davies, Dixon, Elhawary, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO: DeMaio
ABS, ABST OR NV: Castillo, Chen, Ellis, Flora, Hadwick, Lackey, Macedo, Patterson, Ta, Tangipa
SENATE FLOOR: 30-0-10
YES: Allen, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Cortese, Durazo, Gonzalez, Grayson, Hurtado, Laird, Limón, McGuire, McNerney, Menjivar, Padilla, Pérez, Reyes, Richardson, Rubio, Smallwood-Cuevas, Stern, Umberg, Wahab, Weber Pierson, Wiener
ABS, ABST OR NV: Alvarado-Gil, Choi, Dahle, Grove, Jones, Niello, Ochoa Bogh, Seyarto, Strickland, Valladares
ASSEMBLY FLOOR: 67-2-11
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Connolly, Davies, Elhawary, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO: DeMaio, Ellis
ABS, ABST OR NV: Castillo, Chen, Dixon, Flora, Hadwick, Johnson, Lackey, Macedo, Patterson, Ta, Tangipa
UPDATED
VERSION: September 12, 2025
CONSULTANT: Riana King and Scott Bain / HEALTH / (916) 319-2097 FN: 0002154
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 512
Author:(Harabedian)
As Amended Ver:September 5, 2025
Majority vote
SUMMARY
Shortens the decision timeline for prior or concurrent authorization requests for health plans and health insurers to be no longer than three business day for standard requests (instead of five days in existing law) if the request is made by electronic submission, and 24 hours for urgent requests involving an imminent and serious threat to the enrollee’s health if the request if made by electronic submission or 48 hours (instead of 72 hours in existing law). Requires Medi-Cal managed care plan (MCMC) plan contracts with the Department of Health Care Services (DHCS) to meet the prior and concurrent authorization timeframes, rather than the faster turnaround timeframes required by this bill.
Senate Amendments
- Apply the shortened timeframe of three business days for standard requests and 24 hours for urgent requests to authorization requests submitted electronically.
- Define "electronic submission" to mean submission through an electronic portal designated by the health plan or health insurer, or an electronic submission in accordance with the California Health and Human Services Data Exchange Framework and applicable federal interoperability rules.
- Require MCMC plan contracts with DHCS to meet the existing law prior and concurrent authorization timeframes.
COMMENTS
Prior authorization is a form of utilization review or utilization management. Utilization review can occur prospectively, retrospectively, or concurrently, and a plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, plans, and enrollees or insureds. There are timelines in the law for plans and insurers to respond to requests once any medical information that is reasonably necessary to make the determination is provided (as described in the summary above). Under this bill, the current law requirements would still apply to MCMC and Program of All-Inclusive Care for the Elderly (PACE) plans, and this bill does affect the existing prescription drug prior authorization requirements.
In 2023, at the request of the Legislature, the California Health Benefits Review Program (CHBRP) conducted a survey of California-regulated plans and insurers and found overall, between 5% and 15% of all covered medical services, and between 16% and 25% of pharmacy benefits, were subject to prior authorization requirements. CHBRP’s survey of state regulated health plans and insurers shows the average time for a manual prior authorization by phone, mail, or fax in 2022 was 100-120 hours (medical benefit) and 30.5-55 hours for pharmacy benefit. For electronic prior authorizations in 2022 the average response time was 12-46 hours (medical benefit) and 31-69 hours for pharmacy benefit.
According to the Author
Delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. The author continues that this bill ensures that health insurers make prior authorization decisions within three business days instead of five days for standard requests submitted electronically, and 24 hours (if submitted electronically) instead of 48 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. The author concludes that by streamlining the process, the bill improves access to care, lowers avoidable health care expenses, and allows providers to focus on patient needs.
Arguments in Support
The California Medical Association (CMA), sponsor of this bill, states that burdensome PA processes contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. CMA continues that adding to these delays are the sluggish response times by health plans to prior authorization requests. CMA states that California currently has some of the slowest response timelines in the nation – 5 business days for non-urgent requests and 72 for urgent requests. CMA argues that these slow-moving response times lead to delays that negatively impact patient health. CMA continues that current prior authorization timelines are inadequate for many patients, and delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians. CMA concludes that by shortening response timelines, this bill ensures that health plans respond to a prior authorization request in a timelier manner, avoiding unnecessary delays to crucial medical care that have resulted in unnecessary pain, the worsening of patients' illnesses and in some cases even death.
Arguments in Opposition
America's Health Insurance Plans (AHIP) believes shortened PA timeframes are not the right approach. AHIP says almost half of PA requests are submitted manually. AHIP launched an initiative to understand the impact of electronic prior authorization that demonstrated faster time to patient care, faster time to decision, and improved information for providers. AHIP says insurance plans have recently announced a series of commitments to streamline and simplify prior authorization, including standardizing electronic prior authorization with a new framework operational and available to plans and providers by January 1, 2027. By 2027 for all coverage types of signatory plans at least 80% of prior authorizations will be answered in real-time. The California Association of Health Plans, the Association of California Life and Health Insurance Companies, and America's Physician Groups propose an alternative to this bill that would mandate all request be submitted electronically, require all necessary information to make an appropriate determination which means plans and insurers can answer at least 80% in real time, and the effective date should be delayed to allow providers sufficient time to comply with electronic submission requirements.
FISCAL COMMENTS
According to the Senate Appropriations Committee:
- The Department of Managed Health Care estimates costs of approximately $314,000 in 2025-26, $689,000 in 2026-27, $671,000 in 2027-28, $951,000 in 2028-29, and $944,000 in 2029-30 and annually thereafter for state operations (Managed Care Fund).
- California Department of Insurance estimates costs of $9,000 in 2025-26 and $21,000 in 2026-27 for state operations (Insurance Fund).
- Unknown potential cost pressures to capitation payments for Medi-Cal managed care plans for administration (General Fund and federal funds).
VOTES:
ASM HEALTH: 13-0-3
YES: Bonta, Addis, Aguiar-Curry, Rogers, Carrillo, Mark González, Krell, Patel, Celeste Rodriguez, Sanchez, Schiavo, Sharp-Collins, Stefani
ABS, ABST OR NV: Chen, Flora, Patterson
ASM APPROPRIATIONS: 12-0-3
YES: Wicks, Arambula, Calderon, Caloza, Dixon, Elhawary, Fong, Mark González, Hart, Pacheco, Pellerin, Solache
ABS, ABST OR NV: Sanchez, Ta, Tangipa
ASSEMBLY FLOOR: 68-1-10
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer‑Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Connolly, Davies, Dixon, Elhawary, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Quirk‑Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO: DeMaio
ABS, ABST OR NV: Castillo, Chen, Ellis, Flora, Hadwick, Lackey, Macedo, Patterson, Ta, Tangipa
UPDATED
VERSION: September 5, 2025
CONSULTANT: Scott Bain and Riana King / HEALTH / (916) 319-2097 FN: 0001798
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 512 |
THIRD READING
Bill No: AB 512
Author: Harabedian (D), et al.
Amended: 9/5/25 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 7/9/25
AYES: Menjivar, Durazo, Gonzalez, Limón, Padilla, Richardson, Rubio, Weber Pierson, Wiener
NO VOTE RECORDED: Valladares, Grove
SENATE APPROPRIATIONS COMMITTEE: 5-0, 8/29/25
AYES: Caballero, Cabaldon, Grayson, Richardson, Wahab
NO VOTE RECORDED: Seyarto, Dahle
ASSEMBLY FLOOR: 68-1, 6/2/25 - See last page for vote
SUBJECT: Health care coverage: prior authorization
SOURCE: California Medical Association
DIGEST:
This bill shortens the required response times for health plans and insurers for prior authorization requests submitted by providers to three business days for requests received via electronic submission (from five business days) for a standard request and 24 hours for requests received via electronic submission or 48 hours for requests received via submissions that are not electronic (from 72 hours) for more urgent requests.
Senate Floor Amendments of 9/5/25 correct a drafting error by removing other specified entities contracting with the Department of Health Care Services (DHCS) from requirements to comply with existing law.
Senate Floor Amendments of 9/3/25 exempt Medi-Cal managed care plans and other entities that contract with DHCS from this bill, while ensuring that Medi-Cal managed care plans and other entities that contract with DHCS comply with prior authorization timelines in existing law.
ANALYSIS:
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Services Plan Act of 1975; the California Department of Insurance (CDI) to regulate health and other insurers; the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [Health and Safety Code [HSC] §1340, et seq., Insurance Code [INS] §106, et seq. and Welfare and Institutions Code [WIC] §14000, et seq.]
- Requires health plans and insurers, and any contracted entity that performs utilization review or utilization management functions, prospectively, retrospectively, or concurrently, based on medical necessity requests to comply with specified requirements, including a decision within five business days of receiving reasonable information to make a decision, conducting retrospective review within 30 days and decisions associated with imminent and serious threat within 72 hours or sooner. [HSC §1367.01 and INS §10123.135]
This bill:
- Requires decisions based on medical necessity to approve, modify, or deny requests by providers prior to or concurrent with the provision of health care services to enrollees or insureds to be made in a timely fashion appropriate for the nature of the enrollee’s or insured’s condition, not to exceed three business days received via electronic submission for standard requests, or 24 hours for urgent requests received via electronic submission and 48 hours via submissions that are not electronic, from the plan’s receipt of the information reasonably necessary and requested by the plan to make the determination.
- Defines “electronic submission” to mean submission through an electronic portal designated by the plan or in accordance with federal interoperability rules, as specified.
Background
Prior authorization. Prior authorization is a form of utilization review or utilization management. Utilization review can occur prospectively, retrospectively, or concurrently, and a plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, plans, and enrollees or insureds. There are timelines in the law for plans and insurers to respond to requests once any medical information that is reasonably necessary to make the determination is provided as described in the existing law summary. California also has a standardized form for prior authorization submissions for prescription drugs. If a health plan or insurer fails to respond to the prior authorization request within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon the receipt of a completed form, the request is deemed granted. Exigent circumstances exist when an enrollee or insured is suffering from a health condition that may seriously jeopardize the enrollee’s or insured’s life, health, or ability to regain maximum function or when an enrollee or insured is undergoing a current course of treatment using a nonformulary drug.
Average length of time for a single prior authorization request. In 2023, at the request of the Legislature, the California Health Benefits Review Program (CHBRP) conducted a survey of California-regulated plans and insurers and found overall, between 5% and 15% of all covered medical services, and between 16% and 25% of pharmacy benefits, were subject to prior authorization requirements. CHBRP’s survey of state regulated health plans and insurers shows the average time for a manual prior authorization by phone, mail, or fax in 2022 was 100-120 hours (medical benefit) and 30.5-55 hours for pharmacy benefit. For electronic prior authorizations in 2022 the average response time was 12-46 hours (medical benefit) and 31-69 hours for pharmacy benefit.
Final Rule. In January of 2024, the Centers for Medicare and Medicaid Services (CMS) issued the CMS Interoperability and Prior Authorization Final Rule CMS-0057-F. The final rule requires impacted payers to send prior authorization decisions within 72 hours for expedited (i.e., urgent) requests and seven calendar days for standard (i.e., non-urgent) requests. Beginning in 2026, impacted payers must provide a specific reason for denied prior authorization decisions, regardless of the method used to send the prior authorization request. Such decisions may be communicated via portal, fax, email, mail, or phone. As with all policies in this final rule, this provision does not apply to prior authorization decisions for drugs.
Comments
Author’s statement. According to the author, delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. This bill ensures that health insurers make prior authorization decisions within 48 hours instead of five days for standard requests and 24 hours instead of 72 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. By streamlining the process, the bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee,
- DMHC estimates costs of approximately $314,000 in 2025-26, $689,000 in 2026-27, $671,000 in 2027-28, $951,000 in 2028-29, and $944,000 in 2029-30 and annually thereafter for state operations (Managed Care Fund).
- CDI estimates costs of $9,000 in 2025-26 and $21,000 in 2026-27 for state operations (Insurance Fund).
- Unknown potential cost pressures to capitation payments for Medi-Cal managed care plans for administration (General Fund and federal funds).
SUPPORT: (Verified 9/5/25)
California Medical Association (source)
AARP
Adventist Health
Alliance of Catholic Health Care, Inc.
ALS Association
American Academy of Pediatrics, California
American Cancer Society Cancer Action Network, Inc.
American Diabetes Association
Association for Clinical Oncology
Association of Northern California Oncologists
California Access Coalition
California Academy of Child and Adolescent Psychiatry
California Association of Medical Product Suppliers
California Behavioral Health Association
California Chapter American College of Cardiology
California Children’s Hospital
California Chronic Care Coalition
California Collaborative for Long-Term Services and Supports
California Commission on Aging
California Hospital Association
California Kidney Care Alliance
California Long Term Care Ombudsman Association
California Neurology Society
California Nurses Association
California Orthopedic Association
California Podiatric Medical Association
California Psychological Association
California Retired Teachers Association
California Rheumatology Alliance
California Society of Health System Pharmacists
California Society of Plastic Surgeons
California State Association of Psychiatrists
CleanEarth4Kids.org
District Hospital Leadership Forum
Fresenius Medical Care North America
Health Access California
Hemophilia Council of California
Loma Linda University Adventist Health Sciences Center
Medical Oncology Association of Southern California
Mental Health America of California
National Health Law Program
Physician Association of California
Planned Parenthood Affiliates of California
Saint Agnes Medical Center
San Francisco Marin Medical Society
Stanford Health Care
U.S. Pain Foundation
United Hospital Association
Western Center on Law & Poverty, Inc.
OPPOSITION: (Verified 9/5/25)
AHIP
America's Physician Groups
Association of California Life & Health Insurance Companies
California Association of Health Plans
California Chamber of Commerce Local Health Plans of California
Local Health Plans of California
ARGUMENTS IN SUPPORT: This bill is sponsored by the California Medical Association (CMA), which writes, “This bill ensures access to care for patients. Burdensome prior authorization processes also contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. In a 2023 physician survey, the American Medical Association found that 93% of physicians reported experiencing care delays for their patients due to prior authorization requirements. Adding to these delays are the sluggish response times by health plans to prior authorization requests. California currently has some of the slowest response timelines in the nation – five business days for nonurgent requests and 72 hours for urgent requests. These slow-moving response times lead to delays that negatively impact patient health. Current prior authorization timelines are inadequate for many patients, especially those with urgent medical needs. Delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians.”
ARGUMENTS IN OPPOSITION: America’s Health Insurance Plans (AHIP) believes shortened prior authorization timeframes are not the right approach. AHIP says almost half of prior authorizations requests are submitted manually. AHIP launched an initiative to understand the impact of electronic prior authorization that demonstrated faster time to patient care, faster time to decision, and improved information for providers. AHIP says insurance plans have recently announced a series of commitments to streamline and simplify prior authorization, including standardizing electronic prior authorization with a new framework operational and available to plans and providers by January 1, 2027. By 2027 for all coverage types of signatory plans at least 80% of prior authorizations will be answered in real-time. The California Association of Health Plans, the Association of California Life and Health Insurance Companies, and America’s Physician Groups propose an alternative to this bill that would mandate all request be submitted electronically, require all necessary information to make an appropriate determination which means plans and insurers can answer at least 80% in real time, and the effective date should be delayed to allow providers sufficient time to comply with electronic submission requirements.
ASSEMBLY FLOOR: 68-1, 6/2/25
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Connolly, Davies, Dixon, Elhawary, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NOES: DeMaio
NO VOTE RECORDED: Castillo, Chen, Ellis, Flora, Hadwick, Lackey, Macedo, Patterson, Ta, Tangipa
Prepared by: Teri Boughton / HEALTH / (916) 651-4111
9/8/25 21:13:59
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 512 |
THIRD READING
Bill No: AB 512
Author: Harabedian (D), et al.
Amended: 7/14/25 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 7/9/25
AYES: Menjivar, Durazo, Gonzalez, Limón, Padilla, Richardson, Rubio, Weber Pierson, Wiener
NO VOTE RECORDED: Valladares, Grove
SENATE APPROPRIATIONS COMMITTEE: 5-0, 8/29/25
AYES: Caballero, Cabaldon, Grayson, Richardson, Wahab
NO VOTE RECORDED: Seyarto, Dahle
ASSEMBLY FLOOR: 68-1, 6/2/25 - See last page for vote
SUBJECT: Health care coverage: prior authorization
SOURCE: California Medical Association
DIGEST:
This bill shortens the required response times for health plans and insurers for prior authorization requests submitted by providers to three business days for requests received via electronic submission (from five business days) for a standard request and 24 hours for requests received via electronic submission or 48 hours for requests received via submissions that are not electronic (from 72 hours) for more urgent requests.
ANALYSIS:
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Services Plan Act of 1975; the California Department of Insurance (CDI) to regulate health and other insurers; the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [Health and Safety Code [HSC] §1340, et seq., Insurance Code [INS] §106, et seq. and Welfare and Institutions Code [WIC] §14000, et seq.]
- Requires health plans and insurers, and any contracted entity that performs utilization review or utilization management functions, prospectively, retrospectively, or concurrently, based on medical necessity requests to comply with specified requirements, including a decision within five business days of receiving reasonable information to make a decision, conducting retrospective review within 30 days and decisions associated with imminent and serious threat within 72 hours or sooner. [HSC §1367.01 and INS §10123.135]
This bill:
- Requires decisions based on medical necessity to approve, modify, or deny requests by providers prior to or concurrent with the provision of health care services to enrollees or insureds to be made in a timely fashion appropriate for the nature of the enrollee’s or insured’s condition, not to exceed three business days received via electronic submission for standard requests, or 24 hours for urgent requests received via electronic submission and 48 hours via submissions that are not electronic, from the plan’s receipt of the information reasonably necessary and requested by the plan to make the determination.
- Defines “electronic submission” to mean submission through an electronic portal designated by the plan or in accordance with federal interoperability rules, as specified.
Background
Prior authorization. Prior authorization is a form of utilization review or utilization management. Utilization review can occur prospectively, retrospectively, or concurrently, and a plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, plans, and enrollees or insureds. There are timelines in the law for plans and insurers to respond to requests once any medical information that is reasonably necessary to make the determination is provided as described in the existing law summary. California also has a standardized form for prior authorization submissions for prescription drugs. If a health plan or insurer fails to respond to the prior authorization request within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon the receipt of a completed form, the request is deemed granted. Exigent circumstances exist when an enrollee or insured is suffering from a health condition that may seriously jeopardize the enrollee’s or insured’s life, health, or ability to regain maximum function or when an enrollee or insured is undergoing a current course of treatment using a nonformulary drug.
Average length of time for a single prior authorization request. In 2023, at the request of the Legislature, the California Health Benefits Review Program (CHBRP) conducted a survey of California-regulated plans and insurers and found overall, between 5% and 15% of all covered medical services, and between 16% and 25% of pharmacy benefits, were subject to prior authorization requirements. CHBRP’s survey of state regulated health plans and insurers shows the average time for a manual prior authorization by phone, mail, or fax in 2022 was 100-120 hours (medical benefit) and 30.5-55 hours for pharmacy benefit. For electronic prior authorizations in 2022 the average response time was 12-46 hours (medical benefit) and 31-69 hours for pharmacy benefit.
Final Rule. In January of 2024, the Centers for Medicare and Medicaid Services (CMS) issued the CMS Interoperability and Prior Authorization Final Rule CMS-0057-F. The final rule requires impacted payers to send prior authorization decisions within 72 hours for expedited (i.e., urgent) requests and seven calendar days for standard (i.e., non-urgent) requests. Beginning in 2026, impacted payers must provide a specific reason for denied prior authorization decisions, regardless of the method used to send the prior authorization request. Such decisions may be communicated via portal, fax, email, mail, or phone. As with all policies in this final rule, this provision does not apply to prior authorization decisions for drugs.
Comments
Author’s statement. According to the author, delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. This bill ensures that health insurers make prior authorization decisions within 48 hours instead of five days for standard requests and 24 hours instead of 72 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. By streamlining the process, the bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee,
- DMHC estimates costs of approximately $314,000 in 2025-26, $689,000 in 2026-27, $671,000 in 2027-28, $951,000 in 2028-29, and $944,000 in 2029-30 and annually thereafter for state operations (Managed Care Fund).
- CDI estimates costs of $9,000 in 2025-26 and $21,000 in 2026-27 for state operations (Insurance Fund).
- Unknown potential cost pressures to capitation payments for Medi-Cal managed care plans for administration (General Fund and federal funds).
SUPPORT: (Verified 8/29/25)
California Medical Association (source)
AARP
Adventist Health
Alliance of Catholic Health Care, Inc.
ALS Association
American Academy of Pediatrics, California
American Cancer Society Cancer Action Network, Inc.
American Diabetes Association
Association for Clinical Oncology
Association of Northern California Oncologists
California Access Coalition
California Academy of Child and Adolescent Psychiatry
California Association of Medical Product Suppliers
California Behavioral Health Association
California Chapter American College of Cardiology
California Children’s Hospital
California Chronic Care Coalition
California Collaborative for Long-Term Services and Supports
California Commission on Aging
California Hospital Association
California Kidney Care Alliance
California Long Term Care Ombudsman Association
California Neurology Society
California Nurses Association
California Orthopedic Association
California Podiatric Medical Association
California Psychological Association
California Retired Teachers Association
California Rheumatology Alliance
California Society of Health System Pharmacists
California Society of Plastic Surgeons
California State Association of Psychiatrists
CleanEarth4Kids.org
District Hospital Leadership Forum
Fresenius Medical Care North America
Health Access California
Hemophilia Council of California
Loma Linda University Adventist Health Sciences Center
Medical Oncology Association of Southern California
Mental Health America of California
National Health Law Program
Physician Association of California
Planned Parenthood Affiliates of California
Saint Agnes Medical Center
San Francisco Marin Medical Society
Stanford Health Care
U.S. Pain Foundation
United Hospital Association
Western Center on Law & Poverty, Inc.
OPPOSITION: (Verified 8/29/25)
AHIP
America's Physician Groups
Association of California Life & Health Insurance Companies
California Association of Health Plans
California Chamber of Commerce Local Health Plans of California
Local Health Plans of California
ARGUMENTS IN SUPPORT: This bill is sponsored by the California Medical Association (CMA), which writes, this bill “This bill ensures access to care for patients. Burdensome prior authorization processes also contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. In a 2023 physician survey, the American Medical Association found that 93% of physicians reported experiencing care delays for their patients due to prior authorization requirements. Adding to these delays are the sluggish response times by health plans to prior authorization requests. California currently has some of the slowest response timelines in the nation – five business days for nonurgent requests and 72 hours for urgent requests. These slow-moving response times lead to delays that negatively impact patient health. Current prior authorization timelines are inadequate for many patients, especially those with urgent medical needs. Delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians.”
ARGUMENTS IN OPPOSITION: America’s Health Insurance Plans (AHIP) believes shortened prior authorization timeframes are not the right approach. AHIP says almost half of prior authorizations requests are submitted manually. AHIP launched an initiative to understand the impact of electronic prior authorization that demonstrated faster time to patient care, faster time to decision, and improved information for providers. AHIP says insurance plans have recently announced a series of commitments to streamline and simplify prior authorization, including standardizing electronic prior authorization with a new framework operational and available to plans and providers by January 1, 2027. By 2027 for all coverage types of signatory plans at least 80% of prior authorizations will be answered in real-time. The California Association of Health Plans, the Association of California Life and Health Insurance Companies, and America’s Physician Groups propose an alternative to this bill that would mandate all request be submitted electronically, require all necessary information to make an appropriate determination which means plans and insurers can answer at least 80% in real time, and the effective date should be delayed to allow providers sufficient time to comply with electronic submission requirements.
ASSEMBLY FLOOR: 68-1, 6/2/25
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Connolly, Davies, Dixon, Elhawary, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NOES: DeMaio
NO VOTE RECORDED: Castillo, Chen, Ellis, Flora, Hadwick, Lackey, Macedo, Patterson, Ta, Tangipa
Prepared by: Teri Boughton / HEALTH / (916) 651-4111
8/29/25 20:39:00
**** END ****
SENATE COMMITTEE ON
Senator Anna Caballero, Chair
2025 - 2026 Regular Session
AB 512 (Harabedian) - Health care coverage: prior authorization
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
AB 512 would revise the timelines for health plans and insurers to make utilization review decisions.
Fiscal Impact:
- The Department of Managed Health Care (DMHC) estimates costs of approximately $314,000 in 2025-26, $689,000 in 2026-27, $671,000 in 2027-28, $951,000 in 2028-29, and $944,000 in 2029-30 and annually thereafter for state operations (Managed Care Fund).
- The California Department of Insurance (CDI) estimates costs of $9,000 in 2025-26 and $21,000 in 2026-27 for state operations (Insurance Fund).
- Unknown potential cost pressures to capitation payments for Medi-Cal managed care plans for administration (General Fund and federal funds).
Background:
Current law authorizes health plans and insurers to use prior authorization, which is a form of utilization review or utilization management, to determine whether to authorize, modify, or deny health care services. Utilization review can occur prospectively, retrospectively, or concurrently, and a health plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, enrollees/insureds, and the public.
Current law requires health plans and insurers to make prior or concurrent authorization decisions, not to exceed 5 business days from the plan’s/insurer’s receipt of the information reasonably necessary and requested by the plan/insurer to make the determination. For urgent requests, such as when an enrollee/insured faces an imminent and serious threat to the enrollee’s/insured’s health, prior or concurrent authorization decisions must be made in a timely fashion, not to exceed 72 hours after the plan’s/insurer’s receipt of the information reasonably necessary and requested by the plan/insurer to make the determination.
Proposed Law:
Specific provisions of the bill would:
- Revise the timeline for health plans and insurers to make prior or concurrent authorization decisions, to no more than 3 business days from the plan’s/insurer’s receipt via electronic submission, or 5 business days from the plan’s/insurer’s receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan/insurer to make the determination.
- Revise the timeline for health plans and insurers to make prior or concurrent authorization decisions for urgent requests, to no more than 24 hours from the plan’s/insurer’s receipt via electronic submission, or 48 hours from the plan’s/insurer’s receipt via submission that is not electronic, of the information reasonably necessary and requested by the plan/insurer to make the determination.
Related Legislation:
SB 306 (Becker) would, among other provisions, require a health plan or insurer to cease requiring prior authorization for the most frequently approved covered health care services. The bill is currently in the Assembly Appropriations Committee.
-- END --
SENATE COMMITTEE ON HEALTH
Senator Caroline Menjivar, Chair
BILL NO: AB 512
AUTHOR: | Harabedian | ||
VERSION: | April 28, 2025 | ||
HEARING DATE: | July 9, 2025 | ||
CONSULTANT: | Teri Boughton | ||
SUBJECT: Health care coverage: prior authorization
SUMMARY:
Shortens the required response times for health plans and insurers for prior authorizations to 48 hours (from five business days) for a standard request and 24 hours (from 72 hours) for urgent requests.
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Services Plan Act of 1975; the California Department of Insurance (CDI) to regulate health and other insurers; the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [HSC §1340, et seq., INS §106, et seq. and WIC §14000, et seq.]
- Requires the criteria or guidelines used by health plans and insurers, or any entities with which plans or insurers contract for utilization review or utilization management functions, to determine whether to authorize, modify, or deny health care services to:
- Be developed with involvement from actively practicing health care providers;
- Be consistent with sound clinical principles and processes;
- Be evaluated, and updated if necessary, at least annually;
- Be disclosed to the provider and the enrollee or insured in that specified case, if used as the basis of a decision to modify, delay, or deny services in a specified case review; and,
- Be available to the public upon request. [HSC §1363.5 and INS §10123.135]
- Requires health plans and insurers, and any contracted entity that performs utilization review or utilization management functions, prospectively, retrospectively, or concurrently, based on medical necessity requests to comply with specified requirements, including a decision within five business days of receiving reasonable information to make a decision, conducting retrospective review within 30 days and decisions associated with imminent and serious threat within 72 hours or sooner. [HSC §1367.01 and INS §10123.135]
- Prohibits any individual, other than a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider, from denying or modifying requests for authorization of services for an enrollee or insured for reasons of medical necessity. Requires the decision to be communicated to the provider within 24 hours of the decision, and the enrollee or insured (in writing) within two business days of the decision. In the case of concurrent review, prohibits discontinuance of care until the treating provider has been notified and has agreed to a care plan that is appropriate for the medical needs of the patient. [HSC §1367.01 and INS §10123.135]
- Establishes requirements for health plans and insurers that use an artificial intelligence (AI), algorithm, or other software tool for utilization review or utilization management functions, and prohibits the AI, algorithm, or other software tool from denying, delaying, or modifying health care services based in whole or in part on medical necessity. [HSC §1367.01 and INS §10123.135]
This bill:
- Requires decisions based on medical necessity to approve, modify, or deny requests by providers prior to the provision of health care services to enrollees or insureds to be made in a timely fashion appropriate for the nature of the enrollee’s or insured’s condition, not to exceed 48 hours for standard requests, or 24 hours for urgent requests, from the plan’s receipt of the information reasonably necessary and requested by the plan to make the determination.
- Defines “urgent” as the enrollee’s or insured’s condition is such that the enrollee or insured faces an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decision making process for standard requests would be detrimental to the enrollee’s or insured’s life or health or could jeopardize the enrollee’s or insured’s ability to regain maximum function.
FISCAL EFFECT:
According to the Assembly Committee on Appropriations:
CDI anticipates no new costs. DMHC anticipates costs associated with an increase in the volume of consumer complaints, additional independent medical review and translation services, reviewing additional plan documents and updating survey methodology and tools to assess plan compliance, an increase in the number of enforcement referrals, and additional information technology and administrative costs. DMHC estimates Managed Care Fund costs as follows:
- $447,000 in fiscal year (FY) 2025-26.
- $1.47 million in FY 2026-27.
- $1.57 million in FY 2027-28.
- $1.4 million in FY2028-29 and annually thereafter.
PRIOR VOTES:
Assembly Floor: | 68 - 1 |
Assembly Appropriations Committee: | 12 - 0 |
Assembly Health Committee: | 13 - 0 |
COMMENTS:
- Author’s statement. According to the author, delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. This bill ensures that health insurers make prior authorization decisions within 48 hours instead of five days for standard requests and 24 hours instead of 72 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. By streamlining the process, the bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs.
- Prior authorization. Prior authorization is a form of utilization review or utilization management. Utilization review can occur prospectively, retrospectively, or concurrently, and a plan or insurer can approve, modify, delay or deny in whole or in part a request based on its medical necessity. California law requires written policies and procedures that are consistent with criteria or guidelines and supported by clinical principles and processes. These policies and procedures must be filed with regulators, and disclosed, upon request, to providers, plans, and enrollees or insureds. There are timelines in the law for plans and insurers to respond to requests once any medical information that is reasonably necessary to make the determination is provided as described in the existing law summary. California also has a standardized form for prior authorization submissions for prescription drugs. If a health plan or insurer fails to respond to the prior authorization request within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon the receipt of a completed form, the request is deemed granted. Exigent circumstances exist when an enrollee or insured is suffering from a health condition that may seriously jeopardize the enrollee’s or insured’s life, health, or ability to regain maximum function or when an enrollee or insured is undergoing a current course of treatment using a nonformulary drug.
- Average length of time for a single prior authorization request. In 2023, at the request of the Legislature, the California Health Benefits Review Program (CHBRP) conducted a survey of California-regulated plans and insurers and found overall, between 5% and 15% of all covered medical services, and between 16% and 25% of pharmacy benefits, were subject to prior authorization requirements. CHBRP’s survey of state regulated health plans and insurers shows the average time for a manual prior authorization by phone, mail, or fax in 2022 was 100-120 hours (medical benefit) and 30.5-55 hours for pharmacy benefit. For electronic prior authorizations in 2022 the average response time was 12-46 hours (medical benefit) and 31-69 hours for pharmacy benefit.
- Final Rule. In January of 2024, the Centers for Medicare and Medicaid Services (CMS) issued the CMS Interoperability and Prior Authorization Final Rule CMS-0057-F. Through the provisions in this final rule, Medicare Advantage (MA) organizations, state Medicaid and Children’s Health Insurance Program (CHIP) Fee-for-Service (FFS) programs, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan (QHP) issuers on the Federally Facilitated Exchanges (FFEs), (collectively “impacted payers”) are required to implement and maintain specified application programming interfaces (APIs) to improve the electronic exchange of health care data, as well as to streamline prior authorization processes. To encourage providers to adopt electronic prior authorization processes, this final rule also adds a new measure for Merit-based Incentive Payment System (MIPS) eligible clinicians under the Promoting Interoperability performance category of MIPS, as well as for eligible hospitals and critical access hospitals (CAHs), under the Medicare Promoting Interoperability Program. Impacted payers have until compliance dates, generally beginning January 1, 2027, to meet the API development and enhancement requirements in this final rule. The exact compliance dates vary by the type of payer. Included in the final rule is a requirement that impacted payers implement and maintain a Prior Authorization API that is populated with its list of covered items and services, can identify documentation requirements for prior authorization approval, and supports a prior authorization request and response. These Prior Authorization APIs must also communicate whether the payer approves the prior authorization request (and the date or circumstance under which the authorization ends), denies the prior authorization request (and a specific reason for the denial), or requests more information. This requirement must be implemented beginning January 1, 2027.
- Prior Authorization Decision Timeframes. The final rule requires impacted payers (excluding QHP issuers on the FFEs) to send prior authorization decisions within 72 hours for expedited (i.e., urgent) requests and seven calendar days for standard (i.e., non-urgent) requests. Beginning in 2026, impacted payers must provide a specific reason for denied prior authorization decisions, regardless of the method used to send the prior authorization request. Such decisions may be communicated via portal, fax, email, mail, or phone. As with all policies in this final rule, this provision does not apply to prior authorization decisions for drugs. This requirement is intended to both facilitate better communication and transparency between payers, providers, and patients, as well as improve providers’ ability to resubmit the prior authorization request, if necessary. Some impacted payers are also subject to existing requirements to provide information about denials to providers, patients, or both through notices. These existing notices are often required in writing, but nothing in this final rule changes these existing requirements. CMS is requiring impacted payers to publicly report certain prior authorization metrics annually by posting them on their website. These operational or process-related prior authorization policies are being finalized with a compliance date starting January 1, 2026, and the initial set of metrics must be reported by March 31, 2026.
- Related legislation. SB 306 (Becker) requires a covered health care service that has been approved 90% or more times in the prior calendar year to be exempt from health plan or health insurer imposed prior authorization for one year for in-network contracted providers.
SB 306 is set to be heard in the Assembly Health Committee on July 15, 2025. - Prior legislation. SB 516 (Skinner of 2024) would have: required DMHC and CDI to issue instructions, including a standard reporting template, to health plans and insurers to report specified information, including all covered health care services, items, and supplies subject to prior authorization; required health plans and insurers to report that information to DMHC or CDI, and would have required DMHC and CDI to evaluate the reports received; required DMHC and CDI, after evaluating the reports, to identify and to publish a list of the most frequently approved or modified services, items, and supplies no longer subject to prior authorization, and how a health plan and insurers could reinstate prior authorization upon a showing of good cause; required DMHC and CDI, within four years of the end date of the prior authorization requirements, to publish a report of those requirements; and, exempted specialized health plans and insurers, except to the extent the plans provide or administer essential health benefits, health plans contracting with DHCS, or a nonprofit health plan with at least 3.5 million enrollees. SB 516 was not heard in the Assembly Health Committee.
SB 598 (Skinner of 2023) would have prohibited a health plan or health insurer from requiring a contracted health professional to complete or obtain a prior authorization for any covered services if the plan or insurer approved or would have approved at least 90% of the requests the health professional submitted in the most recent one-year contracted period. SB 598 was held in the Assembly Appropriations Committee.
SB 250 (Pan of 2022) would have prohibited a health plan or insurer from requiring, for a period of two years, a contracted health care provider to obtain prior authorization for any health care services if the health plan or insurer approved, or would have approved, at least 90% of the prior authorization requests that a provider submitted in the most recent one-year contracted period. SB 250 would have required a health plan or insurer to include physician representation in developing prior authorization criteria, provided that a physician has the right to have an appeal of a prior authorization decision conducted by a physician of the same or similar specialty, and prohibited a health plan or insurer from requiring a physician to file an appeal challenging an adverse result of a prior authorization request before filing an independent medical review. SB 250 was held on the Assembly Appropriations Committee suspense file.
- Support. This bill is sponsored by the California Medical Association (CMA), which writes, this bill “takes a balanced approach to reforming the prior and concurrent authorization process by shortening timelines for health plans to review and respond to prior authorization requests to 24 hours for urgent requests and 48 hours for nonurgent requests. This bill ensures access to care for patients. Burdensome prior authorization processes also contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. In a 2023 physician survey, the American Medical Association found that 93% of physicians reported experiencing care delays for their patients due to prior authorization requirements. Adding to these delays are the sluggish response times by health plans to prior authorization requests. California currently has some of the slowest response timelines in the nation – five business days for nonurgent requests and 72 hours for urgent requests. These slow-moving response times lead to delays that negatively impact patient health. Current prior authorization timelines are inadequate for many patients, especially those with urgent medical needs. Delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians.”
- Oppose unless amended. America’s Health Insurance Plans (AHIP) believes shortened prior authorization timeframes are not the right approach. AHIP says almost half of prior authorizations requests are submitted manually. AHIP launched an initiative to understand the impact of electronic prior authorization that demonstrated faster time to patient care, faster time to decision, and improved information for providers. AHIP says insurance plans have recently announced a series of commitments to streamline and simplify prior authorization, including standardizing electronic prior authorization with a new framework operational and available to plans and providers by January 1, 2027. By 2027 for all coverage types of signatory plans at least 80% of prior authorizations will be answered in real-time. The California Association of Health Plans, the Association of California Life and Health Insurance Companies, and America’s Physician Groups propose an alternative to this bill that would mandate all request be submitted electronically, require all necessary information to make an appropriate determination which means plans and insurers can answer at least 80% in real time, and the effective date should be delayed to allow providers sufficient time to comply with electronic submission requirements.
- Amendments. In response to discussions with this Committee about the use of electronic submission of prior authorization, the author has developed amendments to tie a three-calendar day response from plans/insurers to prior/concurrent authorization standard requests submitted electronically and a five-calendar day response for submissions that are not electronic. The Chair has requested calendar days be revised to business days and to apply the same framework to urgent requests: 24 hour response time for electronic prior authorization submissions and 48 hours for prior authorization submissions that are not electronic.
SUPPORT AND OPPOSITION:
Support: California Medical Association (sponsor)
AARP
Adventist Health
Alliance of Catholic Health Care, Inc.
ALS Association
American Academy of Pediatrics, California
American Cancer Society Cancer Action Network, Inc.
American Diabetes Association
Association for Clinical Oncology
Association of Northern California Oncologists
California Academy of Child and Adolescent Psychiatry
California Association of Medical Product Suppliers
California Behavioral Health Association
California Chapter American College of Cardiology
California Chronic Care Coalition
California Collaborative for Long-Term Services and Supports
California Commission on Aging
California Hospital Association
California Kidney Care Alliance
California Long Term Care Ombudsman Association
California Neurology Society
California Nurses Association
California Orthopedic Association
California Podiatric Medical Association
California Psychological Association
California Retired Teachers Association
California Rheumatology Alliance
California Society of Health System Pharmacists
California Society of Plastic Surgeons
California State Association of Psychiatrists
District Hospital Leadership Forum
Fresenius Medical Care North America
Health Access California
Hemophilia Council of California
Loma Linda University Adventist Health Sciences Center
Medical Oncology Association of Southern California
Mental Health America of California
National Health Law Program
Physician Association of California
Planned Parenthood Affiliates of California
Saint Agnes Medical Center
San Francisco Marin Medical Society
Stanford Health Care
U.S. Pain Foundation
United Hospital Association
Western Center on Law & Poverty, Inc.
Oppose: America's Physician Groups (unless amended)
Association of California Life & Health Insurance Companies (unless amended)
California Association of Health Plans (unless amended)
California Chamber of Commerce (unless amended)
Local Health Plans of California (unless amended)
-- END --
ASSEMBLY THIRD READING
ATR Bill Id:AB 512
Author:(Harabedian)
As Amended Ver:April 28, 2025
Majority vote
SUMMARY
Shortens the timeline for prior or concurrent authorization requests to be no longer than 48 hours for standard requests or 24 hours for urgent requests.
Major Provisions
COMMENTS
Background. Utilization management (UM) and utilization review (UR) are processes used by health plans to evaluate and manage the use of health care services. UR can occur prospectively, retrospectively, or concurrently and a plan can approve, modify, delay or deny in whole or in part a request based on its medical necessity. Prior authorization is a UR technique used by health plans that requires patients to obtain approval of a service or medication before care is provided. Prior authorization is intended to allow plans to evaluate whether care that has been prescribed is medically necessary for purposes of coverage. Prior authorization is one type of UM tool that's used by health plans, along with others such as concurrent review and step therapy, to control costs, limit unnecessary care, and evaluate safety and appropriateness of a service.
Overall impact of prior authorization. In 2023, the California Health Benefits Review Program (CHBRP) published a report to help the Legislature better understand the ways in which prior authorization is used in California. CHBRP noted that prior authorization is an imperfect instrument that's utilized in a myriad of ways. This poses a challenge for policymakers, payers, patients, and providers since prior authorization is generally intended to decrease costs and waste, but it may also contribute to delays in treatment and additional barriers to care. Currently, evidence is limited as to the extent to which health insurance uses prior authorization and its impact on the performance of the health care system, patient access to appropriate care, and the health and financial interests of the general public. Despite the limited evidence, there is clear frustration from both patients and providers regarding prior authorization practices. According to CHBRP, complaints range from the time required to complete the initial authorization request and pursue denials, to delays in care, to a general lack of transparency regarding the process and criteria used to evaluate prior authorization requests. CHBRP further notes that people with disabilities, younger patients, African Americans, and people with lower incomes are more likely to report administrative burdens, including delays in care, due to prior authorization.
Cost impacts. One common reason prior authorization is used is to reduce and control health care spending. Total national health expenditures as a share of the gross domestic product have increased steadily over time. While the overall increase in health care spending can be largely attributed to increased cost of services and increased utilization, there is another important piece that drives both increased utilization and cost of services. Unnecessary medical care or wasteful health care spending, such as administrative complexities and fraud, are additional drivers. CHBRP cites recent study estimates that between 20% and 25% of all health care spending in the United States is a result of wasteful and unnecessary spending, as well as missed opportunities to provide appropriate care. Health plans and insurers operating in California responding to CHBRP's query on areas of highest fraud and abuse noted that waste and abuse may occur more frequently when low value or medically unnecessary care is delivered. Behavioral health – particularly applied behavioral analysis – was identified by health plans/insurers as a leading fraud risk.
Access to and utilization of care. Across state-regulated commercial plans and policies, 100% of enrollees are subject to some sort of prior authorization in their benefits. Plans reported that between 5% to 15% of all covered medical services and 16% to 25% of pharmacy services were subject to prior authorization. Evidence regarding whether prior authorization improves patient safety and ensures medically appropriate care is provided is mixed. Across studies reviewed by CHBRP, a sizable share of prior authorization denials were overturned upon appeal, ranging from 40% to 82% of denials being overturned. In instances when prior authorization is initially denied, a patient may need to pay out-of-pocket for services or may delay treatment due to lack of coverage. Much of the published literature regarding the impact of prior authorization focuses on prescription medications, finding that prior authorization requirements result in lower utilization of medications and decreases medication adherence.
Administrative burden. According to the American Medical Association (AMA), prior authorization leads to substantial administrative burdens for physicians, taking time away from direct patient care while costing practices money. AMA's 2024 physician survey on prior authorization found that on average, physicians and their staff spend 13 hours each week completing prior authorizations and 40% of physicians have staff who work exclusively on prior authorization. One in three physicians reported that prior authorization requests are often or always denied and 93% reported that prior authorization leads to care delays for their patients. 89% of physicians reported that prior authorization somewhat or significantly increases physician burnout.
Antiquated systems. According to CHBRP, many aspects of prior authorization workflow still rely on the resource-intense use of paper forms, telephone calls, facsimile communications, and portal access. Contributing to the resource intense process is the type of technology (or lack of) used by providers and plans. Although many providers have transitioned to electronic health records (EHRs), for some providers, the cost to do so is prohibitive. Additionally, not all EHRs easily communicate with other EHRs, thereby still requiring a person to manually transfer information from one system to another. In light of these challenges, there are ongoing state and federal efforts to improve data sharing across health care entities to improve processes like prior authorization.
In January of 2024, the federal Centers for Medicare & Medicaid Services (CMS) released the CMS Interoperability and Prior Authorization Final Rule. This rule emphasizes the need to improve health information exchange to achieve appropriate and necessary access to health records for patients, healthcare providers, and payers. The rule also focuses on efforts to improve prior authorization processes through policies and technology, to help ensure that patients remain at the center of their own care. Impacted payers are required to implement certain provisions by January 1, 2026 and meet remaining requirements by January 1, 2027.
AB 133 (Committee on Budget), Chapter 143, Statutes of 2021, established the California Health and Human Services (CalHHS) Data Exchange Framework (DxF) and required CalHHS to finalize a data sharing agreement by July 1, 2022. The DxF defines the entities that will be subject to these new data exchange rules and sets forth a common set of terms, conditions, and obligations to support secure, real-time access to and exchange of health and social services information, in compliance with applicable federal, state, and local laws, regulations, and policies. DxF is not a new technology or centralized data repository, it is an agreement across health and human services systems and providers to share information safely. Many health care entities were required to participate beginning January 2024. Remaining entities are required to participate by January 2026.
According to the Author
Delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. The author continues that this bill ensures that health insurers make prior authorization decisions within 48 hours instead of five days for standard requests and 24 hours instead of 48 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. The author concludes that by streamlining the process, the bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs.
Arguments in Support
The California Medical Association (CMA), sponsor of this bill, states that burdensome prior authorization processes contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. CMA continues that adding to these delays are the sluggish response times by health plans to prior authorization requests. CMA states that California currently has some of the slowest response timelines in the nation – 5 business days for non-urgent requests and 72 for urgent requests. CMA argues that these slow-moving response times lead to delays that negatively impact patient health. CMA continues that current prior authorization timelines are inadequate for many patients, and delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians. CMA concludes that by shortening response timelines, this bill ensures that health plans respond to a prior authorization request in a timelier manner, avoiding unnecessary delays to crucial medical care that have resulted in unnecessary pain, the worsening of patients' illnesses and in some cases even death.
Arguments in Opposition
The California Association of Health Plans (CAHP) and Association of California Life and Health Insurance Companies (ACLHIC) oppose this bill, they state they share the goal of ensuring timely access to medically necessary care, but believe the proposed timelines are operationally burdensome, will negatively impact the health care system, and will lead to the exact opposite goal the bill is trying to achieve. CAHP and ACLHIC highlight operational challenges an unintended consequences with this bill, including increased administrative burden on providers, potential for increased denial rates, and increased cost of health care. CAHP and ACLHIC suggest alternative approaches to this bill, including mandating that all authorization requests be submitted electronically, requiring clinically complete requests, excluding prescription drug authorizations, and delaying the implementation date.
FISCAL COMMENTS
According to the Assembly Committee on Appropriations:
- The California Department of Insurance (CDI) anticipates no new costs.
- The Department of Managed Health Care (DMHC) anticipates costs associated with an increase in the volume of consumer complaints, additional independent medical review and translation services, reviewing additional plan documents and updating survey methodology and tools to assess plan compliance, an increase in the number of enforcement referrals, and additional information technology and administrative costs. DMHC estimates Managed Care Fund costs as follows:
- $447,000 in fiscal year (FY) 2025-26.
- $1.47 million in FY 2026-27.
- $1.57 million in FY 2027-28.
- $1.4 million in FY2028-29 and annually thereafter.
VOTES
ASM HEALTH: 13-0-3
YES: Bonta, Addis, Aguiar-Curry, Rogers, Carrillo, Mark González, Krell, Patel, Celeste Rodriguez, Sanchez, Schiavo, Sharp-Collins, Stefani
ABS, ABST OR NV: Chen, Flora, Patterson
ASM APPROPRIATIONS: 12-0-3
YES: Wicks, Arambula, Calderon, Caloza, Dixon, Elhawary, Fong, Mark González, Hart, Pacheco, Pellerin, Solache
ABS, ABST OR NV: Sanchez, Ta, Tangipa
UPDATED
VERSION: April 28, 2025
CONSULTANT: Riana King / HEALTH / (916) 319-2097 FN: 0000670
Date of Hearing: May 14, 2025
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 512
Author:(Harabedian) – As Amended Ver:April 28, 2025
Policy Committee: | Health | Vote: | 13 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill shortens the timelines for a health plan or health insurer to decide on a prior or concurrent authorization request, to no longer than 48 hours for a standard request, and no longer than 24 hours for an urgent request.
FISCAL EFFECT:
The California Department of Insurance anticipates no new costs.
The Department of Managed Health Care (DMHC) anticipates costs associated with an increase in the volume of consumer complaints, additional independent medical review and translation services, reviewing additional plan documents and updating survey methodology and tools to assess plan compliance, an increase in the number of enforcement referrals, and additional information technology and administrative costs. DMHC estimates Managed Care Fund costs as follows:
- $447,000 in fiscal year (FY) 2025-26.
- $1.47 million in FY 2026-27.
- $1.57 million in FY 2027-28.
- $1.4 million in FY2028-29 and annually thereafter.
COMMENTS:
- Purpose. According to the author, delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. The author contends that by streamlining the process, this bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs.
The California Medical Association (CMA), sponsor of this bill, states burdensome prior authorization processes contribute to more adverse effects on patient outcomes, especially when they result in delays in treatment, and health plans’ sluggish response times to prior authorization requests add to the delays. CMA states California currently has some of the slowest response timelines in the nation – 5 business days for non-urgent requests and 72 for urgent requests. CMA argues these slow-moving response times lead to delays that negatively impact patient health.
- Background. In 2023, the California Health Benefits Review Program (CHBRP) published a report to help the Legislature better understand the ways in which prior authorization, which results in the denials, delays, or modifications addressed in this bill, is used in California. CHBRP noted that prior authorization generally intended to decrease costs and waste, but it may also contribute to delays in treatment and additional barriers to care. Health plans and insurers commonly assert prior authorization is also intended to ensure patient safety and appropriate use of treatments. CHBRP reported 40% to 82% of prior authorization denials were overturned, suggesting a high frequency of inappropriate denials, which may delay treatment and, in the case of prescription medications, decrease patient adherence. CHBRP further notes people with disabilities, younger patients, African Americans, and people with lower incomes are more likely to report administrative burdens, including delays in care, due to prior authorization.
The American Medical Association (AMA) asserts prior authorization leads to substantial administrative burdens for physicians, taking time away from direct patient care while costing practices money. AMA’s 2024 physician survey found that on average, physicians and their staff spend 13 hours each week completing prior authorizations and 40% of physicians have staff who work exclusively on prior authorization. 89% of physicians reported prior authorization increases physician burnout. - Oppose Unless Amended. The California Association of Health Plans (CAHP) and Association of California Life and Health Insurance Companies (ACLHIC) argue the review timelines are unrealistic and unworkable, and are concerned with the potential for compromised quality of review, and difficulty in providing peer-to-peer review. CAHP and ACLHIC request amendments that mandate all appeals be submitted electronically by providers, require all necessary clinical information be included in the appeal, and exclude prescriptions drug authorizations, and delay implementation.
- Related and Prior Legislation. Numerous bills currently under consideration, including AB 384 (Connolly), AB 510 (Addis), AB 539 (Schiavo), AB 574 (Mark González), AB 669 (Haney), and SB 306 (Becker) address prior authorization. Several bills introduced in previous legislative sessions attempted to make larger, more systematic changes, but were not enacted. These bills include SB 516 (Skinner) and SB 598 (Skinner), of the 2023-24 Legislative Session, and SB 250 (Pan) and AB 1880 (Arambula), of the 2021-22 Legislative Session.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: April 22, 2025
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 512
Author:(Harabedian) – As Amended Ver:April 11, 2025
SUBJECT: Health care coverage: prior authorization.
SUMMARY: Shortens the timeline for prior authorization requests to be no longer than 48 hours for standard requests or 24 hours for urgent requests. Specifically, this bill:
- Requires decisions based on medical necessity to approve, modify, or deny requests by a provider prior to the provision of health care services to be made in a timely fashion that does not exceed 48 hours for standard requests or 24 hours for urgent requests upon the health plan or health insurer’s receipt of the information reasonably necessary and requested by the health plan or health insurer to make the determination.
- Defines “urgent” to mean the enrollee or insured’s condition is such that they face an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or that the normal timeframe for the decision-making process for standard requests would be detrimental to the enrollee’s life or health or could jeopardize the enrollee’s ability to regain maximum function.
EXISTING LAW:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 and the California Department of Insurance (CDI) to regulate health insurance under the Insurance Code. [Health and Safety Code (HSC) § 1340, et seq., Insurance Code (INS) § 106, et seq.]
- Requires the criteria or guidelines used by health plans and insurers, or any entities with which plans or insurers contract for utilization review (UR) or utilization management (UM) functions, to determine whether to authorize, modify, or deny health care services to:
- Be developed with involvement from actively practicing health care providers;
- Be consistent with sound clinical principles and processes;
- Be evaluated, and updated if necessary, at least annually;
- If used as the basis of a decision to modify, delay, or deny services in a specified case under review, be disclosed to the provider and the enrollee or insured in that specified case; and,
- Be available to the public upon request. [HSC § 1363.5 and INS § 10123.135]
- Requires health plans to demonstrate that medical decisions are rendered by qualified medical providers, unhindered by fiscal and administrative management. [HSC § 1367]
- Requires health plans and disability insurers and any contracted entity that performs UR or UM functions, prospectively, retrospectively, or concurrently, based on medical necessity requests to comply with specified requirements. [HSC § 1367.01 and INS § 10123.135]
- Requires decisions to approve, modify, or deny, based on medical necessity, requests by providers prior to, or concurrent with the provision of health care services to be made in a timely fashion that does not to exceed five business days from the health plan or health insurer’s receipt of the information reasonably necessary and requested by the plan to make the determination. Requires, in cases where the review is retrospective, the decision to be communicated to the individual who received services, or to the individual’s designee, within 30 days of the receipt of information that is reasonably necessary to make this determination, and be communicated to the provider in a manner that is consistent with current law. [HSC § 1367.01 and INS § 10123.135]
- Requires decisions to approve, modify, or deny requests by providers prior to, or concurrent with, the provision of health care services, to be made in a timely fashion appropriate for the nature of the enrollee or insured’s condition, not to exceed 72 hours when an individual’s condition is such that they face an imminent and serious threat to their health, including, but not limited to, the potential loss of life, limb, or other major bodily function, or the normal timeframe for the decision-making process would be detrimental to the enrollee’s life or health or could jeopardize the enrollee’s ability to regain maximum function, after the plan’s receipt of the information reasonably necessary and requested by the plan to make the determination. [HSC § 1367.01 and INS § 10123.135]
FISCAL EFFECT: Unknown. This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, delays in prior authorization create unnecessary barriers to timely medical care, leading to worsened patient outcomes, increased healthcare costs, and provider burnout. The author continues that this bill ensures that health insurers make prior authorization decisions within 48 hours instead of five days for standard requests and 24 hours instead of 48 hours for urgent cases, reducing delays that prevent patients from receiving necessary treatment. The author concludes that by streamlining the process, the bill improves access to care, lowers avoidable healthcare expenses, and allows providers to focus on patient needs
- BACKGROUND. UM and UR are processes used by health plans to evaluate and manage the use of health care services. UR can occur prospectively, retrospectively, or concurrently and a plan can approve, modify, delay or deny in whole or in part a request based on its medical necessity. Prior authorization is a UR technique used by health plans that requires patients to obtain approval of a service or medication before care is provided. Prior authorization is intended to allow plans to evaluate whether care that has been prescribed is medically necessary for purposes of coverage. Prior authorization is one type of UM tool that’s used by health plans, along with others such as concurrent review and step therapy, to control costs, limit unnecessary care, and evaluate safety and appropriateness of a service.
- Overall impact of prior authorization. In 2023, the California Health Benefits Review Program (CHBRP) published a report to help the Legislature better understand the ways in which prior authorization is used in California. CHBRP noted that prior authorization is an imperfect instrument that’s utilized in a myriad of ways. This poses a challenge for policymakers, payers, patients, and providers since prior authorization is generally intended to decrease costs and waste, but it may also contribute to delays in treatment and additional barriers to care. Currently, evidence is limited as to the extent to which health insurance uses prior authorization and its impact on the performance of the health care system, patient access to appropriate care, and the health and financial interests of the general public. Despite the limited evidence, there is clear frustration from both patients and providers regarding prior authorization practices. According to CHBRP, complaints range from the time required to complete the initial authorization request and pursue denials, to delays in care, to a general lack of transparency regarding the process and criteria used to evaluate prior authorization requests. CHBRP further notes that people with disabilities, younger patients, African Americans, and people with lower incomes are more likely to report administrative burdens, including delays in care, due to prior authorization.
- Cost impacts. One common reason prior authorization is used is to reduce and control health care spending. Total national health expenditures as a share of the gross domestic product have increased steadily over time. While the overall increase in health care spending can be largely attributed to increased cost of services and increased utilization, there is another important piece that drives both increased utilization and cost of services. Unnecessary medical care or wasteful health care spending, such as administrative complexities and fraud, are additional drivers. CHBRP cites recent study estimates that between 20% and 25% of all health care spending in the United States is a result of wasteful and unnecessary spending, as well as missed opportunities to provide appropriate care. Health plans and insurers operating in California responding to CHBRP’s query on areas of highest fraud and abuse noted that waste and abuse may occur more frequently when low value or medically unnecessary care is delivered. Behavioral health – particularly applied behavioral analysis – was identified by health plans/insurers as a leading fraud risk.
- Access to and utilization of care. Across state-regulated commercial plans and policies, 100% of enrollees are subject to some sort of prior authorization in their benefits. Plans reported that between 5% to 15% of all covered medical services and 16% to 25% of pharmacy services were subject to prior authorization. Evidence regarding whether prior authorization improves patient safety and ensures medically appropriate care is provided is mixed. Across studies reviewed by CHBRP, a sizable share of prior authorization denials were overturned upon appeal, ranging from 40% to 82% of denials being overturned. In instances when prior authorization is initially denied, a patient may need to pay out-of-pocket for services or may delay treatment due to lack of coverage. Much of the published literature regarding the impact of prior authorization focuses on prescription medications, finding that prior authorization requirements result in lower utilization of medications and decreases medication adherence.
- Administrative burden. According to the American Medical Association (AMA), prior authorization leads to substantial administrative burdens for physicians, taking time away from direct patient care while costing practices money. AMA’s 2024 physician survey on prior authorization found that on average, physicians and their staff spend 13 hours each week completing prior authorizations and 40% of physicians have staff who work exclusively on prior authorization. One in three physicians reported that prior authorization requests are often or always denied and 93% reported that prior authorization leads to care delays for their patients. 89% of physicians reported that prior authorization somewhat or significantly increases physician burnout.
- Antiquated systems. According to CHBRP, many aspects of prior authorization workflow still rely on the resource-intense use of paper forms, telephone calls, facsimile communications, and portal access. Contributing to the resource intense process is the type of technology (or lack of) used by providers and plans. Although many providers have transitioned to electronic health records (EHRs), for some providers, the cost to do so is prohibitive. Additionally, not all EHRs easily communicate with other EHRs, thereby still requiring a person to manually transfer information from one system to another. In light of these challenges, there are ongoing state and federal efforts to improve data sharing across health care entities to improve processes like prior authorization.
In January of 2024, the federal Centers for Medicare & Medicaid Services (CMS) released the CMS Interoperability and Prior Authorization Final Rule. This rule emphasizes the need to improve health information exchange to achieve appropriate and necessary access to health records for patients, healthcare providers, and payers. The rule also focuses on efforts to improve prior authorization processes through policies and technology, to help ensure that patients remain at the center of their own care. Impacted payers are required to implement certain provisions by January 1, 2026 and meet remaining requirements by January 1, 2027.
AB 133 (Committee on Budget), Chapter 143, Statutes of 2021, established the California Health and Human Services (CalHHS) Data Exchange Framework (DxF) and required CalHHS to finalize a data sharing agreement by July 1, 2022. The DxF defines the entities that will be subject to these new data exchange rules and sets forth a common set of terms, conditions, and obligations to support secure, real-time access to and exchange of health and social services information, in compliance with applicable federal, state, and local laws, regulations, and policies. DxF is not a new technology or centralized data repository, it is an agreement across health and human services systems and providers to share information safely. Many health care entities were required to participate beginning January 2024. Remaining entities are required to participate by January 2026.
- SUPPORT. The California Medical Association (CMA), sponsor of this bill, states that burdensome prior authorization processes contribute to more adverse effects on patient care outcomes, especially when they result in delays in treatment. CMA continues that adding to these delays are the sluggish response times by health plans to prior authorization requests. CMA states that California currently has some of the slowest response timelines in the nation – 5 business days for non-urgent requests and 72 for urgent requests. CMA argues that these slow-moving response times lead to delays that negatively impact patient health. CMA continues that current prior authorization timelines are inadequate for many patients, and delays can cause unnecessary suffering, increased healthcare costs due to complications from postponed treatment, and administrative burdens on physicians. CMA concludes that by shortening response timelines, this bill ensures that health plans respond to a prior authorization request in a timelier manner, avoiding unnecessary delays to crucial medical care that have resulted in unnecessary pain, the worsening of patients’ illnesses and in some cases even death.
- OPPOSSED UNLESS AMENDED. The California Association of Health Plans (CAHP) and Association of California Life and Health Insurance Companies (ACLHIC) oppose this bill, they state they share the goal of ensuring timely access to medically necessary care, but believe the proposed timelines are operationally burdensome, will negatively impact the health care system, and will lead to the exact opposite goal the bill is trying to achieve. CAHP and ACLHIC highlight operational challenges an unintended consequences with this bill, including increased administrative burden on providers, potential for increased denial rates, and increased cost of health care. CAHP and ACLHIC suggest alternative approaches to this bill, including mandating that all authorization requests be submitted electronically, requiring clinically complete requests, excluding prescription drug authorizations, and delaying the implementation date.
- RELATED LEGISLATION.
- AB 384 (Connolly) would prohibit a health plan, health insurer, or Medi-Cal from requiring prior authorization for an individual to be admitted to medically necessary 24-hour inpatient settings for mental health and substance use disorders (SUDs) and for any medically necessary health care services provided to an individual while admitted for that care. AB 384 is currently pending in the Assembly Health Committee.
- AB 510 (Addis) would require, upon request, an appeal or grievance regarding a decision by a health plan or health insurer delaying, denying, or modifying a health care service based in whole or in part on medical necessity, to be reviewed by a peer physician or health care professional of the same or similar specialty as the requesting provider. AB 510 is currently pending in the Assembly Health Committee.
- AB 539 (Schiavo) would require a prior authorization for a health care service to remain valid for a period of at least one year from the date of approval. AB 539 is currently pending in the Assembly Health Committee.
- AB 574 (Mark González) would prohibit a health plan or health insurer that provides coverage for physical therapy (PT) from requiring prior authorization for the initial 12 treatment visits for a new episode of care for PT.
- AB 669 (Haney) would prohibit concurrent or retrospective review of medical necessity for the first 28 days of in-network inpatient SUD stay. Would prohibit concurrent or retrospective review of medical necessity of in-network outpatient SUD visits. Would prohibit retrospective review of medical necessity for the first 28 days of in-network intensive outpatient or partial hospitalization SUD services, as specified. Would prohibit prior authorization for in-network coverage of medically necessary outpatient prescription drugs to treat SUD. AB 669 is currently pending in the Assembly Health Committee.
- SB 306 (Becker) would prohibit a health plan or health insurer, or an entity with which the plan or insurer contracts, from imposing prior authorization or prior notification for one calendar year on a covered service that was approved 90% or more of the time in the prior calendar year. SB 306 is currently pending in the Senate Health Committee.
- PREVIOUS LEGISLATION.
- SB 516 (Skinner) of 2024, would have required DMHC and CDI, by July 1, 2025, to issue instructions, including a standard reporting template, to health plans and insurers to report specified information, including all covered health care services, items, and supplies subject to prior authorization. SB 516 was not heard in the Assembly Health Committee.
- SB 598 (Skinner) of 2023 would have prohibited a health plan or insurer from requiring a contracted health professional to complete or obtain a prior authorization for any covered health care services if the plan or insurer approved or would have approved not less than 90% of the prior authorization requests they submitted in the most recent completed one-year contracted period. SB 598 was held on suspense in the Assembly Appropriations Committee.
- SB 250 (Pan) of 2022 was similar to SB 598 and was held on suspense in the Assembly Appropriations Committee.
- AB 1880 (Arambula) of 2022 would have required a health plan or insurer's UM process to ensure that an appeal of a denial, is reviewed by a clinical peer, as specified. Would have defined clinical peer as a physician or other health professional who holds an unrestricted license or certification from any state and whose practice is in the same or a similar specialty as the medical condition, procedures, or treatment under review. AB 1880 was vetoed by Governor Newsom who stated in part:
“Health plans and health insurers should make every effort to streamline UM processes and reduce barriers to all medically necessary care. However, the bill's requirements, which are limited to denied authorizations for prescription drugs, are duplicative of California's existing IMR requirements, which provide enrollees, insureds, and their designated representatives with the opportunity to request an external review from an independent provider. I encourage the Legislature to pursue options that leverage existing requirements and resources, rather than creating duplicative new processes.”
- AB 1268 (Rodriguez) of 2019 would have required a health plan or health insurer, on or before July 1, 2020, and annually on July 1 thereafter, to report to the appropriate department the number of times in the preceding calendar year that it approved or denied each of the 30 health care services for which prospective review was most frequently requested. AB 1268 was held on suspense in the Assembly Appropriations Committee.
- PROPOSED AMENDMENTS. Current law sets forth identical timelines for prior authorization and concurrent review requests. This bill only updates timelines for prior authorization requests, leaving longer concurrent review timelines in statute. This split in review timelines may create unintended consequences. When timelines for prior authorization become shorter than those for concurrent review, health plans may shift to lean on concurrent reviews for denials if they have a longer period to do so. This could lead to an increase in denials of coverage during or after receipt of services, which would be burdensome to consumers who would have to grapple with either discontinuing or being responsible for paying for a treatment plan they have already started. The committee may wish to amend this bill to shorten timelines for both prior authorization and concurrent reviews, keeping them consistent as they are under existing law.
- POLICY COMMENTS.
- Alignment with data solutions. As noted in the background of this analysis, many aspects of the UR workflow still rely on the resource-intense use of paper forms, telephone calls, facsimile communications, and portal access. While there is no doubt that shortening UR timelines will improve patient access to care and reduce provider burden, the timelines in this bill will be difficult to meet if providers and plans are still relying on outdated information sharing systems. The author and sponsors may wish to work with stakeholders to ensure that this bill is aligned with ongoing state and federal efforts to improve data sharing and technological connectivity between patients, providers, and payers to ensure that the timelines it is setting can be met.
- Best approach for addressing issues with UR and UM. This committee is reviewing a number of bills aiming to address the problems that current UR and UM processes create in terms of access to care and physician burden. The volume of bills introduced on the topic demonstrate the level of Legislative determination to improve UR and UM processes for Californians. However, there is a divide on how to best approach such improvements. Some bills aim to address UR and UM processes through systemic level changes such as speeding up processing times, reducing the overall volume of services that require prior authorization, or extending authorization periods. Others aim to tackle problems at a more individual level by removing or altering UM and UR processes for specific services or conditions. While there is a clear need and desire for progress on improving the UR and UM experience, the Legislature will need to consider what the best approach is for all Californians. Altering structural processes? Or removing barriers for priority services and conditions?
REGISTERED SUPPORT / OPPOSITION:
Support
California Medical Association (sponsor)
AARP
Alliance of Catholic Health Care, Inc.
ALS Association
American Academy of Pediatrics, California
American Diabetes Association
Association for Clinical Oncology
Association of Northern California Oncologists
California Academy of Child and Adolescent Psychiatry
California Chapter American College of Cardiology
California Chronic Care Coalition
California Hospital Association
California Orthopedic Association
California Retired Teachers Association
California Rheumatology Alliance
California Society of Plastic Surgeons
California State Association of Psychiatrists
Medical Oncology Association of Southern California
Mental Health America of California
Saint Agnes Medical Center
Stanford Health Care
U.S. Pain Foundation
United Hospital Association
Opposition
None on file
Analysis Prepared by: Riana King / HEALTH / (916) 319-2097
Discussed in Hearing
Assembly Floor
Senate Floor
Senate Standing Committee on Appropriations
Senate Standing Committee on Health
Assembly Floor
Assembly Standing Committee on Health
Bill Author
Bill Co-Author(s):